<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Moclobemide</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Moclobemide">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Moclobemide</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Moclobemide</b> (sold as <b>Amira</b>, <b>Aurorix</b>,<span class="mw-ref" id="cite_ref-pmid8023056_7-0"><a href="#cite_note-pmid8023056-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> <b>Clobemix</b> , <b>Depnil</b> and <b>Manerix</b><span class="mw-ref" id="cite_ref-pmid7905288_8-0"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span>) is a Reversible Inhibitor of Monoamine oxidase-A (RIMA) drug primarily used to treat depression and social anxiety.<span class="mw-ref" id="cite_ref-pmid8875133_9-0"><a href="#cite_note-pmid8875133-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-AMH_10-0"><a href="#cite_note-AMH-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-BNF_11-0"><a href="#cite_note-BNF-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It is not approved for use in the United States,<span class="mw-ref" id="cite_ref-pmid10063483_12-0"><a href="#cite_note-pmid10063483-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> but is approved in other Western countries such as Canada, the UK<span class="mw-ref" id="cite_ref-BNF_11-1"><a href="#cite_note-BNF-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> and Australia (TGA approved in December 2000).<span class="mw-ref" id="cite_ref-SANDOZ_13-0"><a href="#cite_note-SANDOZ-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> It is produced by affiliates of the Hoffmann–La Roche pharmaceutical company. Initially, Aurorix was also marketed by Roche in South Africa, but was withdrawn after its patent rights expired and Cipla Medpro's Depnil and Pharma Dynamic's Clorix became available at half the cost.</p>


<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Moclobemide</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Moclobemide.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Moclobemide.svg.png" data-file-width="512" data-file-height="205" data-file-type="drawing" height="100" width="250"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Moclobemide3Dan.gif" tppabs="https://ptable.com/wiki/compounds/I/m/Moclobemide3Dan.gif" data-file-width="256" data-file-height="256" data-file-type="bitmap" height="225" width="225"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Amira, Aurorix, Clobemix, Depnil, Manerix</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/cons/moclobemide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/cons/moclobemide.html'" tppabs="https://www.drugs.com/cons/moclobemide.html" class="external text external">Micromedex Detailed Consumer Information</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B3<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>oral</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>N06AG02<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N06AG02  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N06AG02'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N06AG02" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>55-95% (increases with repeat administration)<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Lancet_2-0"><a href="#cite_note-Lancet-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>50%<span class="mw-ref" id="cite_ref-Lancet_2-1"><a href="#cite_note-Lancet-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-MAOA_3-0"><a href="#cite_note-MAOA-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Hepatic<span class="mw-ref" id="cite_ref-pmid2248086_4-0"><a href="#cite_note-pmid2248086-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-pmid2248087_5-0"><a href="#cite_note-pmid2248087-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>1-2 hours,<span class="mw-ref" id="cite_ref-pmid2248087_5-1"><a href="#cite_note-pmid2248087-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> 4 hours (elderly)<span class="mw-ref" id="cite_ref-Lancet_2-2"><a href="#cite_note-Lancet-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Renal, Faecal (&lt;5%)<span class="mw-ref" id="cite_ref-MAOA_3-1"><a href="#cite_note-MAOA-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">4-chloro-<i>N</i>-(2-morpholin-4-ylethyl)benzamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=71320-77-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=71320-77-9'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=71320-77-9" class="external text external">71320-77-9</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/4235  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/4235'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/4235" class="external text external">4235</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7428  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7428'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7428" class="external text external">7428</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01171  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01171'" tppabs="https://www.drugbank.ca/drugs/DB01171" class="external text external">DB01171</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.4087.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.4087.html'" tppabs="http://www.chemspider.com/Chemical-Structure.4087.html" class="external text external">4087</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=PJ0Y7AZB63  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=PJ0Y7AZB63'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=PJ0Y7AZB63" class="external text external">PJ0Y7AZB63</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D02561  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D02561'" tppabs="https://www.kegg.jp/entry/D02561" class="external text external">D02561</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:83531  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:83531'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:83531" class="external text external">CHEBI:83531</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL86304  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL86304'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL86304" class="external text external">ChEMBL86304</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID9040554  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID9040554'" tppabs="https://comptox.epa.gov/dashboard/DTXSID9040554" class="external text external">DTXSID9040554</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.163.935  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.163.935'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.163.935" class="external text external">100.163.935</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>13</sub><span>H</span><sub>17</sub><span>Cl</span><span>N</span><sub>2</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">268.74</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=Clc1ccc%28cc1%29C%28%3DO%29NCCN2CCOCC2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=Clc1ccc%28cc1%29C%28%3DO%29NCCN2CCOCC2'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=Clc1ccc%28cc1%29C%28%3DO%29NCCN2CCOCC2" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Clc1ccc(cc1)C(=O)NCCN2CCOCC2</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C13H17ClN2O2/c14-12-3-1-11(2-4-12)13(17)15-5-6-16-7-9-18-10-8-16/h1-4H,5-10H2,(H,15,17)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:YHXISWVBGDMDLQ-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=457784738&page2=Moclobemide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=457784738&page2=Moclobemide'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=457784738&page2=Moclobemide" class="external text external">(verify)</a></span></span></td></tr></tbody></table>
<p>No significant rise in blood pressure occurs when moclobemide is combined with amines such as <a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">tyramine</a>-containing foods or pressor amine drugs, unlike with the older irreversible and non-selective monoamine oxidase inhibitors (MAOIs), which cause a severe rise in blood pressure with such combination.<span class="mw-ref" id="cite_ref-pmid8875133_9-1"><a href="#cite_note-pmid8875133-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Due to the lack of anticholinergic, cardiovascular, cognitive and psychomotor impairments moclobemide is advantageous in the elderly as well as those with cardiovascular disease.<span class="mw-ref" id="cite_ref-pmid8875133_9-2"><a href="#cite_note-pmid8875133-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Reversible selective MAOIs such as moclobemide are widely underprescribed due to the misconception that the side effect profiles are analogous to that of the irreversible and non-selective MAOIs.<span class="mw-ref" id="cite_ref-pmid9074307_14-0"><a href="#cite_note-pmid9074307-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> MAOIs such as moclobemide are reported to have a relatively fast onset of action compared to other antidepressant drug classes,<span class="mw-ref" id="cite_ref-pmid1609114_15-0"><a href="#cite_note-pmid1609114-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> and have good long-term tolerability in terms of side effects.<span class="mw-ref" id="cite_ref-pmid1394027_16-0"><a href="#cite_note-pmid1394027-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>Tolerance does not seem to occur; research has found that moclobemide retains its beneficial therapeutic properties in depression for at least a year.<span class="mw-ref" id="cite_ref-Amrein-1993_17-0"><a href="#cite_note-Amrein-1993-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<ul><li>Unipolar depression. Moclobemide has demonstrated effectiveness and efficacy in the treatment and management of major depressive disorder,<span class="mw-ref" id="cite_ref-pmid7980178_18-0"><a href="#cite_note-pmid7980178-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> with both endogenous and non-endogenous depression responding; in addition moclobemide has a fast onset of action compared to other antidepressants and is significantly more tolerable than the tricyclic antidepressants.<span class="mw-ref" id="cite_ref-pmid2248063_19-0"><a href="#cite_note-pmid2248063-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> Due to a very good safety profile and very low incidence of side effects moclobemide is likely to have a high level of acceptability by individuals suffering from depression.<span class="mw-ref" id="cite_ref-pmid1609337_20-0"><a href="#cite_note-pmid1609337-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Higher doses (&gt;450<span>&nbsp;</span>mg/day) may be more effective in severe depression, while patients treated with a lower dose tend to respond less well than those treated with tricyclic antidepressants.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></li></ul>

<dl><dd>Psychotic depression, unipolar endogenous depression, melancholic depression, retarded depression, agitated depression and neurotic depression all respond to moclobemide.<span class="mw-ref" id="cite_ref-pmid7717094_22-0"><a href="#cite_note-pmid7717094-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> As does atypical depression.<span class="mw-ref" id="cite_ref-pmid8440808_23-0"><a href="#cite_note-pmid8440808-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Unipolar endogenous depression is reported to have the best response to moclobemide therapy.<span class="mw-ref" id="cite_ref-Angst-1993_24-0"><a href="#cite_note-Angst-1993-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-Woggon-1993_25-0"><a href="#cite_note-Woggon-1993-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Individuals suffering from depression who are given moclobemide are twice as likely to improve on moclobemide than on placebo.<span class="mw-ref" id="cite_ref-Silverstone-1993_26-0"><a href="#cite_note-Silverstone-1993-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> A concern of antidepressant adverse effects is sexual dysfunction; however, moclobemide has actually been found to increase the libido and also improve impaired erection, ejaculation and orgasm.<span class="mw-ref" id="cite_ref-pmid8468436_27-0"><a href="#cite_note-pmid8468436-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> Cardiovascular toxicity is a concern with antidepressants such as tricyclic antidepressants as well as the irreversible MAOIs; when cardiovascular toxicity is a concern, SSRIs or the reversible MAOIs such as moclobemide are an option as they lack or have a significantly reduced level of cardiovascular toxicity in terms of adverse effect as well as in overdose.<span class="mw-ref" id="cite_ref-pmid8353831_28-0"><a href="#cite_note-pmid8353831-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></dd></dl>

<dl><dd>The effectiveness of moclobemide in agitated depression is equivalent to that of <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a> and sedative antidepressants such as <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">mianserin</a> and <a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">maprotiline</a>. The therapeutic response in agitated depressive individuals is similar to that seen in non-agitated depression; however, a past history of use of antidepressants reduces the chance of successful therapeutic response. The addition of a benzodiazepine to moclobemide therapy has not been found to be of benefit in this population group.<span class="mw-ref" id="cite_ref-pmid8557884_29-0"><a href="#cite_note-pmid8557884-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> Moclobemide cause less side effects than <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a>. <span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> and it has better tolerability compared to TCAs.<span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></dd></dl>

<ul><li>Bipolar depression. While not generally recommended as a monotherapy for bipolar depression (as with all antidepressants) in one clinical trial it appeared (although statistical significance at the p=0.05 was not reached) as though moclobemide was equally effective as <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a> at reducing depressive symptoms, but had a significantly lower risk of causing a manic switch.<span class="mw-ref" id="cite_ref-BPD_34-0"><a href="#cite_note-BPD-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> This is in line with recent findings that MAOIs as a class are superior to other antidepressants (in terms of both their relatively low rate of manic switching and their efficacy) in the treatment of bipolar depression.<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></li>
<li>Dysthymia; moclobemide has been found to be effective in the treatment and management of this depressive disorder.<span class="mw-ref" id="cite_ref-pmid19698626_36-0"><a href="#cite_note-pmid19698626-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></li>
<li>Social phobia. Moclobemide has been found to be effective for the treatment of social anxiety disorder in both short and long-term placebo controlled clinical trials.<span class="mw-ref" id="cite_ref-pmid8923114_37-0"><a href="#cite_note-pmid8923114-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> Moclobemide is effective but not as effective as the irreversible MAOIs in the treatment of social phobia.<span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Maximal benefits can take 8 – 12 weeks to manifest.<span class="mw-ref" id="cite_ref-pmid1393304_39-0"><a href="#cite_note-pmid1393304-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> There is a high risk of treatment failure if there is co-morbid alcohol abuse, however.<span class="mw-ref" id="cite_ref-pmid9466158_40-0"><a href="#cite_note-pmid9466158-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> The Australian Medicines Handbook lists social phobia as an accepted but not a licensed indication.<span class="mw-ref" id="cite_ref-AMH_10-1"><a href="#cite_note-AMH-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> The use of moclobemide in the treatment of social anxiety disorder has given mixed results with a tendency of response at higher doses (&gt;300 mg/d) compared with placebo.<span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></li></ul>

<ul><li>Smoking cessation. Moclobemide has been tested in heavy dependent smokers against placebo based on the theory that tobacco smoking could be a form of self-medicating of major depression,<span class="mw-ref" id="cite_ref-Berlin-1995_42-0"><a href="#cite_note-Berlin-1995-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> and moclobemide could therefore help increase abstinence rates due to moclobemide mimicking the MAO-A inhibiting effects of tobacco smoke. Moclobemide was administered for 3 months and then stopped; at 6 months follow-up it was found those who had taken moclobemide for 3 months had a much higher successful quit rate than those in the placebo group. However, at 12-month follow-up the difference between the placebo group and the moclobemide group was no longer significant.<span class="mw-ref" id="cite_ref-Hughes-2007_43-0"><a href="#cite_note-Hughes-2007-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></li>
<li>Panic disorder. Moclobemide is useful in the treatment and management of panic disorder.<span class="mw-ref" id="cite_ref-pmid9466172_44-0"><a href="#cite_note-pmid9466172-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> Panic disorder is mentioned as an accepted but unlicensed indication in the Australian Medicines Handbook.<span class="mw-ref" id="cite_ref-AMH_10-2"><a href="#cite_note-AMH-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></li>
<li>ADHD. Two small studies assessing the benefit of moclobemide in people with attention deficit disorder found that moclobemide produced favourable results.<span class="mw-ref" id="cite_ref-pmid7717094_22-1"><a href="#cite_note-pmid7717094-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></li>
<li>Fibromyalgia, moclobemide has been found to improve pain and functioning in this group of people.<span class="mw-ref" id="cite_ref-Heymann-_45-0"><a href="#cite_note-Heymann--45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></li>
<li>Migraine. Moclobemide has been reported to be effective in the treatment of migraine and chronic tension headache.<span class="mw-ref" id="cite_ref-pmid8349478_46-0"><a href="#cite_note-pmid8349478-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-pmid9324719_47-0"><a href="#cite_note-pmid9324719-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></li></ul>

<p>Similar to other MAOIs, reversible MAOIs such as moclobemide may also be effective in a range of other psychiatric disorders.<span class="mw-ref" id="cite_ref-pmid7717094_22-2"><a href="#cite_note-pmid7717094-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-pmid2248064_48-0"><a href="#cite_note-pmid2248064-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> Menopausal flushing may also respond to moclobemide.<span class="mw-ref" id="cite_ref-pmid7915384_49-0"><a href="#cite_note-pmid7915384-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> Moclobemide may also have benefit for some patients with Parkinson's Disease by extending and enhancing the effects of l-dopa.<span class="mw-ref" id="cite_ref-pmid7593732_50-0"><a href="#cite_note-pmid7593732-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></p>

<p>In efficacy studies for the treatment of major depressive disorder, moclobemide has been found to be significantly more effective than placebo, as effective as the tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs), and somewhat less effective than the older, irreversible MAOIs <a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">phenelzine</a> and <a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">tranylcypromine</a>. In terms of tolerability, however, moclobemide was found to be comparable to the SSRIs and better tolerated than the TCAs and older MAOIs.<span class="mw-ref" id="cite_ref-pmid10063483_12-1"><a href="#cite_note-pmid10063483-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> There is some evidence that moclobemide on its own or in combination with other antidepressants such as SSRIs is also effective for treatment resistant depression and that the combination can be administered without the development of serotonin syndrome; however, further research is needed before such a combination can be recommended.<span class="mw-ref" id="cite_ref-pmid8875133_9-3"><a href="#cite_note-pmid8875133-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-pmid8968657_51-0"><a href="#cite_note-pmid8968657-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> Follow-up studies show that ongoing use of antidepressants leads to continuing improvement in depression over time; and also have demonstrated that moclobemide retains its therapeutic efficacy as an antidepressant for at least a year. This long-term efficacy is equivalent to that seen with other antidepressant classes.<span class="mw-ref" id="cite_ref-pmid9074307_14-1"><a href="#cite_note-pmid9074307-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>People on irreversible MAOIs have to discontinue these antidepressants two weeks before general anesthesia, however, the use of moclobemide due to its reversible nature, would allow such patients to possibly continue antidepressant therapy.<span class="mw-ref" id="cite_ref-pmid1546140_52-0"><a href="#cite_note-pmid1546140-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-Blom-Peters-1993_53-0"><a href="#cite_note-Blom-Peters-1993-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></p>

<p>A dexamethasone suppression test (DST) and plasma and urine methoxyhydroxyphenylglycol (MHPG) test can be used to estimate who is likely to respond to moclobemide antidepressant therapy.<span class="mw-ref" id="cite_ref-pmid8488751_54-0"><a href="#cite_note-pmid8488751-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pregnancy_and_lactation">Pregnancy and lactation</h3></summary>
    
<p>The doses of moclobemide in breast milk are very low (0.06% of moclobemide being recovered in breast milk) and therefore it has been concluded that moclobemide is unlikely to have any adverse effect on a suckling baby.<span class="mw-ref" id="cite_ref-pmid7905288_8-1"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Children">Children</h3></summary>
    
<p>Use in children is not recommended as there is insufficient data to assess their safety and efficacy in these patients.<span class="mw-ref" id="cite_ref-AMH_10-3"><a href="#cite_note-AMH-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-BNF_11-2"><a href="#cite_note-BNF-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Elderly">Elderly</h3></summary>
    
<p>Reversible MAOIs such as moclobemide may have advantages in the treatment of depression associated with Alzheimer's disease due to its effect on noradrenaline.<span class="mw-ref" id="cite_ref-pmid1546130_55-0"><a href="#cite_note-pmid1546130-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> Cognitive impairments have been found to improve in people with dementia when depression is treated with moclobemide.<span class="mw-ref" id="cite_ref-pmid7717094_22-3"><a href="#cite_note-pmid7717094-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> Due to its superior safety profile, moclobemide has been recommended as a first line agent for the treatment of depression in the elderly.<span class="mw-ref" id="cite_ref-pmid2248077_56-0"><a href="#cite_note-pmid2248077-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> Due to the side effect profile of moclobemide, it may be a better option for this sub group of people than other antidepressants.<span class="mw-ref" id="cite_ref-pmid1546128_57-0"><a href="#cite_note-pmid1546128-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> Research has found evidence that moclobemide may be able to counter anti-cholinergic (Scopolamine) induced cognitive impairments thus making moclobemide a good choice in the depression in the elderly and those with dementia.<span class="mw-ref" id="cite_ref-pmid2248080_58-0"><a href="#cite_note-pmid2248080-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>The incidence of adverse events is not correlated with age; however, adverse events occur more often in females than in males.<span class="mw-ref" id="cite_ref-pmid7593736_59-0"><a href="#cite_note-pmid7593736-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> Moclobemide is regarded as a generally safe antidepressant and due to its favorable side effect profile, it can be considered a first-line therapeutic antidepressant.<span class="mw-ref" id="cite_ref-pmid7622819_60-0"><a href="#cite_note-pmid7622819-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> Side effects of moclobemide are exceptionally low,<span class="mw-ref" id="cite_ref-pmid1609337_20-1"><a href="#cite_note-pmid1609337-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> with insomnia, headache and dizziness being the most commonly reported side effects in the initial stages of therapy with moclobemide.<span class="mw-ref" id="cite_ref-pmid7954486_61-0"><a href="#cite_note-pmid7954486-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span> Many antidepressants have an adverse effect on sexual function; however, treatment with moclobemide has actually been found to improve sexual function.<span class="mw-ref" id="cite_ref-pmid8144126_62-0"><a href="#cite_note-pmid8144126-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> Moclobemide does not have any adverse effect on cognitive abilities, thus there are no impairments of moclobemide therapy on memory, attention functions nor is ability to drive a motor vehicle affected adversely.<span class="mw-ref" id="cite_ref-pmid8174512_63-0"><a href="#cite_note-pmid8174512-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span>. Moclobemide, even at high doses of 600<span>&nbsp;</span>mg, does not impair the ability to drive a motor vehicle.<span class="mw-ref" id="cite_ref-pmid7905288_8-2"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid1377119_64-0"><a href="#cite_note-pmid1377119-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> The tolerability of moclobemide is similar in women and men and it is also well tolerated in the elderly.<span class="mw-ref" id="cite_ref-pmid2123366_65-0"><a href="#cite_note-pmid2123366-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> Moclobemide has been found to be superior to tricyclic and irreversible MAOI antidepressants in terms of side effects, as it does not cause anticholinergic, sedative or cardiovascular adverse effects<span class="mw-ref" id="cite_ref-pmid8875133_9-4"><a href="#cite_note-pmid8875133-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> as well as not causing weight gain.<span class="mw-ref" id="cite_ref-pmid1377119_64-1"><a href="#cite_note-pmid1377119-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span></p>

<p>Unlike the irreversible MAOIs there is no evidence of liver toxicity with moclobemide.<span class="mw-ref" id="cite_ref-pmid1394030_66-0"><a href="#cite_note-pmid1394030-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span> Moclobemide has a similar efficacy profile compared to other antidepressants while being superior to the classic MAOIs and the tricyclics in terms of tolerance and safety profile.<span class="mw-ref" id="cite_ref-pmid7741983_67-0"><a href="#cite_note-pmid7741983-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> Moclobemide has little effect on psychomotor functions.<span class="mw-ref" id="cite_ref-pmid2248062_68-0"><a href="#cite_note-pmid2248062-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> Other side effects include nausea, insomnia, tremor and lightheadedness; orthostatic hypotension (dizziness upon standing) is uncommon even among the elderly.<span class="mw-ref" id="cite_ref-pmid10063483_12-2"><a href="#cite_note-pmid10063483-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Behavioural toxicity or other impairments relating to everyday living does not occur with moclobemide, except that in doses of 400<span>&nbsp;</span>mg or higher peripheral reaction time may be impaired.<span class="mw-ref" id="cite_ref-pmid1546141_69-0"><a href="#cite_note-pmid1546141-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> Peripheral oedema has been associated with moclobemide.<span class="mw-ref" id="cite_ref-pmid1630391_70-0"><a href="#cite_note-pmid1630391-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span></p>

<p>Most of the side effects are transient and disappear within 2 weeks of treatment.<span class="mw-ref" id="cite_ref-pmid7593727_71-0"><a href="#cite_note-pmid7593727-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span> Serious fatigue, headache, restlessness, nervousness and sleep disturbances have been described as side effects from moclobemide therapy.<span class="mw-ref" id="cite_ref-Rimón-1993_72-0"><a href="#cite_note-Rimón-1993-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span> A paradoxical worsening of depression has been reported in some individuals in several studies,<span class="mw-ref" id="cite_ref-pmid8354766_73-0"><a href="#cite_note-pmid8354766-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> and reports of suicide or suicidal ideation have been reported as a rare adverse effect of moclobemide.<span class="mw-ref" id="cite_ref-pmid7941097_74-0"><a href="#cite_note-pmid7941097-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> Overall, antidepressants decrease the risk of suicide.<span class="mw-ref" id="cite_ref-pmid9272192_75-0"><a href="#cite_note-pmid9272192-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span> Moclobemide is believed to have only small proconvulsant effects;<span class="mw-ref" id="cite_ref-pmid9512919_76-0"><a href="#cite_note-pmid9512919-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span> however, rarely seizures may occur.<span class="mw-ref" id="cite_ref-pmid7954487_77-0"><a href="#cite_note-pmid7954487-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span> Hypertension has been reported to occur very rarely with moclobemide therapy.<span class="mw-ref" id="cite_ref-pmid10063483_12-3"><a href="#cite_note-pmid10063483-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>Moclobemide is relatively well tolerated. The following are the potential adverse effects and their respective incidences:<span class="mw-ref" id="cite_ref-SANDOZ_13-1"><a href="#cite_note-SANDOZ-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-AURORIX_78-0"><a href="#cite_note-AURORIX-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span></p>

<dl><dt>Common (&gt;1% incidence) adverse effects</dt></dl>
<ul><li>Nausea</li>
<li>Dry mouth</li>
<li>Constipation</li>
<li>Diarrhoea</li>
<li>Insomnia</li>
<li>Dizziness</li>
<li>Anxiety</li>
<li>Restlessness</li></ul>

<dl><dt>Uncommon/Rare (&lt;1%) adverse effects</dt></dl>
<div class="div-col columns column-width" style="-moz-column-width: 18em; -webkit-column-width: 18em; column-width: 18em;   ">
<ul><li>Difficulties falling asleep</li>
<li>Nightmares/dreams</li>
<li>Hallucinations</li>
<li>Memory disturbances</li>
<li>Confusion</li>
<li>Disorientation</li>
<li>Delusions</li>
<li>Increased depression</li>
<li>Excitation/irritability</li>
<li>Hypomania</li>
<li>Mania</li>
<li>Aggressive behaviour</li>
<li>Apathy</li>
<li>Tension</li>
<li>Suicidal ideation</li>
<li>Suicidal behaviour</li>
<li>Migraine</li>
<li>Extrapyramidal effects</li>
<li>Tinnitus</li>
<li>Paraesthesia</li>
<li>Dysarthria</li>
<li>Heartburn</li>
<li>Gastritis</li>
<li>Meteorism</li>
<li>Indigestion</li>
<li>Hypertension</li>
<li>Bradycardia</li>
<li>Extrasystoles</li>
<li>Angina/chest pain</li>
<li>Phlebetic symptoms</li>
<li>Flushing</li>
<li>Exanthema/rash</li>
<li>Allergic skin reaction</li>
<li>Itching</li>
<li>Gingivitis</li>
<li>Stomatitis</li>
<li>Dry skin</li>
<li>Conjunctivitis</li>
<li>Pruritus</li>
<li>Urticaria</li>
<li>Disturbances of micturition (dysuria, polyuria, tenesmus)</li>
<li>Metrorrhagia</li>
<li>Prolonged menstruation</li>
<li>General malaise</li>
<li>Skeletal/muscular pain</li>
<li>Altered taste sensations</li>
<li>Hot flushes/cold sensation</li>
<li>Photopsia</li>
<li>Dyspnoea</li>
<li>Visual disturbances</li>
<li>Increased hepatic enzymes without associated clinical sequelae.</li></ul>
</div>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Contraindications">Contraindications</h3></summary>
    
<p>Avoid use in:<span class="mw-ref" id="cite_ref-AMH_10-4"><a href="#cite_note-AMH-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<ul><li>Confusional states</li>
<li>Bipolar disorder (although it seems less likely than imipramine to cause a manic switch<span class="mw-ref" id="cite_ref-BPD_34-1"><a href="#cite_note-BPD-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span>)</li>
<li>Phaeochromocytoma</li></ul>

<p>and <i>caution</i> is recommended in:<span class="mw-ref" id="cite_ref-BNF_11-3"><a href="#cite_note-BNF-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>
<ul><li>Agitated/excited patients</li>
<li>Thyrotoxicosis</li></ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Interactions">Interactions</h3></summary>
    
<dl><dt>Drug</dt></dl>
<p>Moclobemide has fewer interactions than irreversible MAOIs. <a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a>, however, causes a significant rise in moclobemide levels and therefore if the combination is used, lower doses of moclobemide have been recommended.<span class="mw-ref" id="cite_ref-pmid2248085_79-0"><a href="#cite_note-pmid2248085-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span> There is little increase in the effects of alcohol when combined with moclobemide<span class="mw-ref" id="cite_ref-pmid2248085_79-1"><a href="#cite_note-pmid2248085-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span> and, in fact, moclobemide causes a reduction in alcohol-related impairments.<span class="mw-ref" id="cite_ref-pmid2248062_68-1"><a href="#cite_note-pmid2248062-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> Moclobemide also interacts with <a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">pethidine/meperidine</a>,<span class="mw-ref" id="cite_ref-pmid1546135_80-0"><a href="#cite_note-pmid1546135-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span> and <a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">dextropropoxyphene</a>.<span class="mw-ref" id="cite_ref-pmid7741983_67-1"><a href="#cite_note-pmid7741983-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> <a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a> in combination with moclobemide increases the risk of cardiovascular adverse effects.<span class="mw-ref" id="cite_ref-pmid8468439_81-0"><a href="#cite_note-pmid8468439-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span> Moclobemide is also likely to interact with <a href="Warfarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Warfarin" title="Warfarin">warfarin</a>.<span class="mw-ref" id="cite_ref-pmid9669190_82-0"><a href="#cite_note-pmid9669190-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span>
The combination of moclobemide with prescription or over the counter sympathomimetic drugs is not recommended due to the potential of significant drug interactions.<span class="mw-ref" id="cite_ref-pmid8713690_83-0"><a href="#cite_note-pmid8713690-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></p>

<p>Serotonin syndrome has been reported when moclobemide has been taken in combination with other serotonin enhancing drugs; however, due to moclobemide's reversible MAO inhibition, serotonin syndrome is significantly less likely to occur with moclobemide than with older irreversible MAOIs.<span class="mw-ref" id="cite_ref-AMH_10-5"><a href="#cite_note-AMH-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-pmid9224903_84-0"><a href="#cite_note-pmid9224903-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span><span class="mw-ref" id="cite_ref-pmid8255982_85-0"><a href="#cite_note-pmid8255982-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span> Serotonin syndrome has been reported when <a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">trazodone</a> was abruptly replaced with moclobemide.<span class="mw-ref" id="cite_ref-pmid16104086_86-0"><a href="#cite_note-pmid16104086-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span> Taking at the same time or starting moclobemide too soon after discontinuing <a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">clomipramine</a>, or other serotonin reuptake inhibitors, such as SSRIs may result in the development of a serotonin syndrome.<span class="mw-ref" id="cite_ref-pmid7741983_67-2"><a href="#cite_note-pmid7741983-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span><span class="mw-ref" id="cite_ref-pmid8443525_87-0"><a href="#cite_note-pmid8443525-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> SNRIs, such as venlafaxine in combination with moclobemide have also been associated with serotonin syndrome.<span class="mw-ref" id="cite_ref-pmid9631680_88-0"><a href="#cite_note-pmid9631680-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span> <a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a>, causes a doubling of the blood plasma levels of moclobemide.<span class="mw-ref" id="cite_ref-pmid7905288_8-3"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Blood plasma levels of <a href="Trimipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimipramine" title="Trimipramine">trimipramine</a> and <a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">maprotiline</a> and possibly other tricyclic antidepressants increase when used in combination with moclobemide and may require dosage adjustments if the combination is used for treatment resistant depression.<span class="mw-ref" id="cite_ref-pmid9271778_89-0"><a href="#cite_note-pmid9271778-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span> The elimination of <a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">zolmitriptan</a> is reduced by moclobemide and if the combination is used, a dosage reduction of zolmitriptan is recommended.<span class="mw-ref" id="cite_ref-pmid9399014_90-0"><a href="#cite_note-pmid9399014-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span> Moclobemide reduces the metabolism of <a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">dextromethorphan</a>.<span class="mw-ref" id="cite_ref-pmid9489930_91-0"><a href="#cite_note-pmid9489930-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span> Moclobemide may decrease metabolism of diazepam, omeprazole, proguanil, propranolol, and others due to inhibition of CYP2C19. <span class="mw-ref" id="cite_ref-92"><a href="#cite_note-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span></p> 

<dl><dt>Dietary</dt></dl>
<p>Irreversible MAOIs can cause unpleasant and occasionally dangerous side effects such as a hypertensive crises after intake of food or drink containing indirectly acting sympathomimetic amines such as <a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">tyramine</a>. This is sometimes referred to as the 'cheese effect'. These side effects are due to irreversible inhibition of MAO in the gut and vasomotor neurones. However, the reversible MAOI antidepressants such as moclobemide have a very different side effect profile in this regard.<span class="mw-ref" id="cite_ref-pmid7905288_8-4"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> The reversible binding to MAO-A by moclobemide allows amines such as tyramine to displace moclobemide from MAO-A allowing its metabolism and removing the risk of a hypertensive crisis that occurs with irreversible MAO inhibition.<span class="mw-ref" id="cite_ref-Lavian-1993_93-0"><a href="#cite_note-Lavian-1993-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span> Of 2300 people in multiple clinical trials who were treated with moclobemide in doses up to 600<span>&nbsp;</span>mg with no dietary restrictions, none experienced a tyramine-mediated hypertensive reaction.<span class="mw-ref" id="cite_ref-pmid2123366_65-1"><a href="#cite_note-pmid2123366-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> As the pressor effect of moclobemide is so low, dietary restrictions are not necessary in people eating a normal diet, in contrast to irreversible MAOIs.<span class="mw-ref" id="cite_ref-pmid8875133_9-5"><a href="#cite_note-pmid8875133-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> However, some rare cheeses that have a high tyramine level may possibly cause a pressor effect and require caution.<span class="mw-ref" id="cite_ref-pmid3283290_94-0"><a href="#cite_note-pmid3283290-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span> The potentiation of the pressor effect of tyramine by moclobemide is only one seventh to one tenth of that of irreversible MAOIs.<span class="mw-ref" id="cite_ref-pmid2248084_95-0"><a href="#cite_note-pmid2248084-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span> In order to minimize this potentiation, postprandial administration (taken after meals) of moclobemide is recommended.<span class="mw-ref" id="cite_ref-pmid7905288_8-5"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> The combined use of moclobemide and <a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">selegiline</a> requires dietary restrictions as the combination can lead to increased sensitivity to the pressor effect of foods containing tyramine.<span class="mw-ref" id="cite_ref-pmid9673855_96-0"><a href="#cite_note-pmid9673855-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span></p>

<p>While moclobemide or the irreversible MAO-B selective inhibitor selegiline taken alone has very little pressor effect, and requires no dietary restriction, the combination of <a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Seligiline" title="Seligiline" class="mw-redirect">seligiline</a> with moclobemide leads to a significant enhancement of the pressor effect and such a combination requires dietary restriction of foods containing high amounts of <a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">tyramine</a>.<span class="mw-ref" id="cite_ref-pmid8857072_97-0"><a href="#cite_note-pmid8857072-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> The combination of moclobemide and a reversible MAO-B inhibitor requires tyramine dietary restrictions.<span class="mw-ref" id="cite_ref-pmid8861736_98-0"><a href="#cite_note-pmid8861736-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Overdose">Overdose</h3></summary>
    
<p>Moclobemide is considered to be less toxic in overdose compared to older antidepressants, such as the tricyclic antidepressants and the irreversible and non-selective MAOIs,<span class="mw-ref" id="cite_ref-pmid8875133_9-6"><a href="#cite_note-pmid8875133-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> making it a safer antidepressant in the elderly or people with physical disorders.<span class="mw-ref" id="cite_ref-pmid1377119_64-2"><a href="#cite_note-pmid1377119-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> Of 18 people who overdosed on moclobemide during clinical trials, all recovered fully and moclobemide was judged to be safe for inpatient as well as outpatient use.<span class="mw-ref" id="cite_ref-pmid1546127_99-0"><a href="#cite_note-pmid1546127-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span> Intoxications with moclobemide as single agent are usually mild; however, when combined with tricyclic or SSRI antidepressants the overdose is much more toxic and potentially fatal.<span class="mw-ref" id="cite_ref-pmid8433071_100-0"><a href="#cite_note-pmid8433071-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span><span class="mw-ref" id="cite_ref-pmid7901695_101-0"><a href="#cite_note-pmid7901695-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span> Moclobemide, is preferred by doctors for patients who are at risk of suicide, due to moclobemide's low toxicity in overdose.<span class="mw-ref" id="cite_ref-pmid7819894_102-0"><a href="#cite_note-pmid7819894-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span> Patients with mixed intoxications (e.g. with other CNS active drugs) may show severe or life-threatening symptoms and should be hospitalized. Treatment is largely symptomatic and should be aimed at maintenance of the vital functions.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Withdrawal_and_tolerance">Withdrawal and tolerance</h3></summary>
    
<p>Withdrawal symptoms appear to be very rare with moclobemide compared to other antidepressants; a single report of relatively mild flu-like symptoms persisting for 7 days after rapid reduction of high dose moclobemide therapy has been reported in one patient.<span class="mw-ref" id="cite_ref-Curtin-2002_103-0"><a href="#cite_note-Curtin-2002-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> Withdrawal of moclobemide causes a rebound in REM sleep.<span class="mw-ref" id="cite_ref-pmid7905288_8-6"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>Moclobemide does not seem to prevent withdrawal symptoms from serotonin reuptake inhibitors.<span class="mw-ref" id="cite_ref-pmid8889907_104-0"><a href="#cite_note-pmid8889907-104" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span></p>

<p>Discontinuation of moclobemide is recommended to be done gradually to minimise side effects (e.g. rapid return of condition being treated and/or the appearance of withdrawal symptoms). Tolerance to the therapeutic effects has been reported in a small number of users of MAOIs including moclobemide.<span class="mw-ref" id="cite_ref-pmid9074307_14-2"><a href="#cite_note-pmid9074307-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Moclobemide_150_mg_tablets.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Moclobemide_150_mg_tablets.jpg" data-file-width="3264" data-file-height="1952" data-file-type="bitmap" height="132" width="220"><div class="thumbcaption" style="text-align: left">A picture of 150 mg tablets of the reversible MAOI drug moclobemide, brand name Aurorix.</div></div></div>
<p>Moclobemide is a <a href="Benzamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzamide" title="Benzamide">benzamide</a>,<span class="mw-ref" id="cite_ref-pmid10063483_12-4"><a href="#cite_note-pmid10063483-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> derivative of <a href="Morpholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morpholine" title="Morpholine">morpholine</a>,<span class="mw-ref" id="cite_ref-pmid9112832_105-0"><a href="#cite_note-pmid9112832-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span> which acts pharmacologically as a selective, reversible inhibitor of monoamine oxidase-A (RIMA),<span class="mw-ref" id="cite_ref-pmid8875133_9-7"><a href="#cite_note-pmid8875133-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> a type of monoamine oxidase inhibitor (MAOI), and increases levels of norepinephrine (noradrenaline), <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a>, and especially <a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">serotonin</a><span class="mw-ref" id="cite_ref-Nair_106-0"><a href="#cite_note-Nair-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span><span class="mw-ref" id="cite_ref-pmid1546143_107-0"><a href="#cite_note-pmid1546143-107" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span> in neuronal cells as well as in synaptic vesicles; extracellular levels also increase which results in increased monoamine receptor stimulation and suppression of REM sleep, down regulation of Beta-3 adrenergic receptors. A single 300<span>&nbsp;</span>mg dose of moclobemide inhibits 80% of monoamine oxidase-A (MAO-A) and 30% of monoamine oxidase-B (MAO-B), blocking the decomposition of norepinephrine, serotonin and, to a lesser extent, dopamine. There is also some evidence of moclobemide possessing neuroprotective properties in rodent models.<span class="mw-ref" id="cite_ref-pmid7905288_8-7"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> There is no cumulative effect of moclobemide centrally when taken long-term.<span class="mw-ref" id="cite_ref-pmid7905288_8-8"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> With long-term use of moclobemide, there is a significant down-regulation of B-adrenoceptors.<span class="mw-ref" id="cite_ref-pmid7905288_8-9"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Single or repeated dosing with 100–300<span>&nbsp;</span>mg of moclobemide leads to a reduction in deaminated metabolites of amines such as 3,4-dihydroxyphenylacetic acid, 3,4-dihydroxyphenylethylglycol as well as <a href="5-Hydroxyindoleacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/5-HIAA" title="5-HIAA" class="mw-redirect">5-HIAA</a>. Excretion of <a href="Homovanillic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Homovanillic_acid" title="Homovanillic acid">homovanillic acid</a> and <a href="Vanillylmandelic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanillylmandelic_acid" title="Vanillylmandelic acid">vanillylmandelic acid</a> via urine is also reduced. There is also a temporary increase in prolactin during initial intake of 100–300<span>&nbsp;</span>mg of moclobemide.<span class="mw-ref" id="cite_ref-pmid7905288_8-10"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> L-dihydroxyphenylalanine is also reduced.<span class="mw-ref" id="cite_ref-pmid8923574_108-0"><a href="#cite_note-pmid8923574-108" style="counter-reset: mw-Ref 108;"><span class="mw-reflink-text">[108]</span></a></span> Inhibition of the serotonin metabolite is less pronounced than the norepinephrine metabolite which suggests there are other major metabolic pathways for serotonin other than MAO-A.<span class="mw-ref" id="cite_ref-pmid7519866_109-0"><a href="#cite_note-pmid7519866-109" style="counter-reset: mw-Ref 109;"><span class="mw-reflink-text">[109]</span></a></span></p>

<p>It has been described as a 'slow binding inhibitor', whereby conformational changes to either moclobemide or the enzyme to MAO-A slowly form a more tightly bound complex, resulting in the non-competitive MAO inhibition by moclobemide.<span class="mw-ref" id="cite_ref-pmid7905288_8-11"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> With three times daily dosing the inhibition on MAO-A was relatively constant with moclobemide.<span class="mw-ref" id="cite_ref-pmid1546145_110-0"><a href="#cite_note-pmid1546145-110" style="counter-reset: mw-Ref 110;"><span class="mw-reflink-text">[110]</span></a></span> The MAO inhibition of moclobemide lasts about 8–10 hours and wears off completely by 24 hours after dosing.<span class="mw-ref" id="cite_ref-pmid7905288_8-12"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid1546143_107-1"><a href="#cite_note-pmid1546143-107" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span> The inhibition of MAO-A by moclobemide is 10 times more potent than the irreversible MAOIs <a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">phenelzine</a> and approximately equivalent to <a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">tranylcypromine</a> and <a href="Isocarboxazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isocarboxazid" title="Isocarboxazid">isocarboxazid</a>.<span class="mw-ref" id="cite_ref-pmid7905288_8-13"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>Moclobemide increases levels of extracellular monoamines and decreases levels of their metabolites in rat brains; tolerance to these effects does not seem to occur with chronic use of moclobemide. Moclobemide lacks anticholinergic effects and cognitive impairments can be improved by moclobemide.<span class="mw-ref" id="cite_ref-Haefely-1993_111-0"><a href="#cite_note-Haefely-1993-111" style="counter-reset: mw-Ref 111;"><span class="mw-reflink-text">[111]</span></a></span> Moclobemide suppresses the unstimulated release of certain proinflammatory cytokines which are believed to be involved in the pathophysiology of major depression and stimulates the release of anti-inflammatory cytokines.<span class="mw-ref" id="cite_ref-pmid10760560_112-0"><a href="#cite_note-pmid10760560-112" style="counter-reset: mw-Ref 112;"><span class="mw-reflink-text">[112]</span></a></span> Long-term treatment with moclobemide leads to an increase in <a href="Cyclic_adenosine_monophosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclic_adenosine_monophosphate" title="Cyclic adenosine monophosphate">cyclic adenosine monophosphate</a> (cAMP) binding to cAMP-dependent protein kinase (PKA).<span class="mw-ref" id="cite_ref-pmid9694007_113-0"><a href="#cite_note-pmid9694007-113" style="counter-reset: mw-Ref 113;"><span class="mw-reflink-text">[113]</span></a></span></p>

<p>Moclobemide is chemically unrelated to irreversible MAOI antidepressants and only has a very weak pressor effect of orally administered <a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">tyramine</a>.<span class="mw-ref" id="cite_ref-pmid2677242_114-0"><a href="#cite_note-pmid2677242-114" style="counter-reset: mw-Ref 114;"><span class="mw-reflink-text">[114]</span></a></span> In humans, the n-oxide metabolites of moclobemide and moclobemide itself are the compounds that produce most of the inhibition of MAO-A; other metabolites are significantly less potent than the parent compound.<span class="mw-ref" id="cite_ref-pmid7905288_8-14"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>In healthy people moclobemide has a relatively small suppressing effect on REM sleep; in contrast, depressed people who have been treated with moclobemide, progressively show improved sleep over a 4-week period, with an increase in stage 2 non-rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep.<span class="mw-ref" id="cite_ref-pmid7905288_8-15"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> There have been conflicting findings with regard to moclobemide altering <a href="Cortisol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cortisol" title="Cortisol">cortisol</a> levels and whether moclobemide increases <a href="Growth_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Growth_hormone" title="Growth hormone">growth hormone</a> levels.<span class="mw-ref" id="cite_ref-pmid7905288_8-16"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">Testosterone</a> levels increase significantly with long-term use of moclobemide in depressed males.<span class="mw-ref" id="cite_ref-Plasma_sex_hormones_and_urinary_biogenic_amine_metabolites_during_treatment_of_male_depressed_patients_with_the_monoamine_oxidase_inhibitor_moclobemide_115-0"><a href="#cite_note-Plasma_sex_hormones_and_urinary_biogenic_amine_metabolites_during_treatment_of_male_depressed_patients_with_the_monoamine_oxidase_inhibitor_moclobemide-115" style="counter-reset: mw-Ref 115;"><span class="mw-reflink-text">[115]</span></a></span></p>

<p>Moclobemide also has neuroprotective properties in its demonstrated anti-hypoxia or anti-ischemia effects; there is a possibility that moclobemide may possess similar neuro-rescuing properties, similar to <a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">selegiline</a>, however, research is required to determine this.<span class="mw-ref" id="cite_ref-pmid7905288_8-17"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Moclobemide has also been demonstrated in a single dose research study to possess antinociceptive properties.<span class="mw-ref" id="cite_ref-pmid8375130_116-0"><a href="#cite_note-pmid8375130-116" style="counter-reset: mw-Ref 116;"><span class="mw-reflink-text">[116]</span></a></span></p>

<p>Platelet MAO is of the MAO-B and this is inhibited only to a small degree in humans; the inhibition is due to low levels of metabolites of moclobemide that have MAO-B inhibiting properties.<span class="mw-ref" id="cite_ref-pmid9663810_117-0"><a href="#cite_note-pmid9663810-117" style="counter-reset: mw-Ref 117;"><span class="mw-reflink-text">[117]</span></a></span> Moclobemide has been reported to be a mixed MAO-A/MAO-B inhibitor in rats but in man, it has been reported to be a pure MAO-A inhibitor,<span class="mw-ref" id="cite_ref-pmid8259692_118-0"><a href="#cite_note-pmid8259692-118" style="counter-reset: mw-Ref 118;"><span class="mw-reflink-text">[118]</span></a></span> blocking the decomposition of norepinephrine, serotonin and, to a lesser extent, dopamine. No reuptake inhibition of any of the neurotransmitters occurs. The pharmacodynamic action encompasses activation, elevation of mood, and improvement of symptoms like dysphoria, fatigue, and difficulties in concentration. The duration and quality of sleep may be improved. In the treatment of depression the antidepressant effect often becomes evident in the first week of therapy (earlier than typically noted with TCAs/SSRIs).</p>

<p>MAO inhibition returns completely back to normal after 24 hours, which allows for changing to another antidepressant within 24 hours of the last dose taken of moclobemide.<span class="mw-ref" id="cite_ref-pmid7905288_8-18"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    
<p>In humans moclobemide is rapidly and almost completely absorbed and totally metabolised via the liver.<span class="mw-ref" id="cite_ref-pmid8582117_119-0"><a href="#cite_note-pmid8582117-119" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span> Peak plasma levels occur 0.3 to 2 hours after oral administration. The bioavailability increases during the first week of therapy from 60% to 80% and more. The elimination half-life is around 2 hours.<span class="mw-ref" id="cite_ref-pmid7905288_8-19"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Lei_120-0"><a href="#cite_note-Lei-120" style="counter-reset: mw-Ref 120;"><span class="mw-reflink-text">[120]</span></a></span> It is moderately bound to plasma proteins, especially albumin.<span class="mw-ref" id="cite_ref-pmid7905288_8-20"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> However, the short disposition half life somewhat increases after repeated dosing; moclobemide has an intermediate elimination half life for <span class="new">systemic clearance</span> and an intermediate volume of distribution.<span class="mw-ref" id="cite_ref-pmid8582117_119-1"><a href="#cite_note-pmid8582117-119" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span> Despite its short half-life the pharmacodynamic action of a single dose persists for approximately 16 hours. The drug is almost completely metabolized in the liver; it is a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6 and CYP1A2.<span class="mw-ref" id="cite_ref-Gram_121-0"><a href="#cite_note-Gram-121" style="counter-reset: mw-Ref 121;"><span class="mw-reflink-text">[121]</span></a></span> Less than 1 percent of the drug is excreted unchanged; 92 percent of the metabolised drug is excreted within the first 12 hours.<span class="mw-ref" id="cite_ref-pmid2248086_4-1"><a href="#cite_note-pmid2248086-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The main metabolites are the N-oxide Ro 12-5637 formed via morpholine N-oxidation and lactam derivative Ro 12-8095 formed via morpholine C-oxidation;<span class="mw-ref" id="cite_ref-Din_122-0"><a href="#cite_note-Din-122" style="counter-reset: mw-Ref 122;"><span class="mw-reflink-text">[122]</span></a></span><span class="mw-ref" id="cite_ref-pmid8329293_123-0"><a href="#cite_note-pmid8329293-123" style="counter-reset: mw-Ref 123;"><span class="mw-reflink-text">[123]</span></a></span> active metabolites are found only in trace amounts. The unchanged drug (less than 1%) as well as the metabolites are excreted renally (in urine). The main degradation pathway of moclobemide is oxidation.<span class="mw-ref" id="cite_ref-pmid2685852_124-0"><a href="#cite_note-pmid2685852-124" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span> About 44 percent of the drug is lost due to the first pass effect through the liver.<span class="mw-ref" id="cite_ref-pmid6538424_125-0"><a href="#cite_note-pmid6538424-125" style="counter-reset: mw-Ref 125;"><span class="mw-reflink-text">[125]</span></a></span> Age and renal function do not affect the pharmacokinetics of moclobemide. However, patients with significantly reduced liver function require dose reductions due to the significant slowing of metabolism of moclobemide.<span class="mw-ref" id="cite_ref-pmid9259175_126-0"><a href="#cite_note-pmid9259175-126" style="counter-reset: mw-Ref 126;"><span class="mw-reflink-text">[126]</span></a></span> Food slows the absorption but does not affect the bioavailability of moclobemide.<span class="mw-ref" id="cite_ref-pmid7905288_8-21"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>Steady state concentrations are established after one week.<span class="mw-ref" id="cite_ref-pmid8582117_119-2"><a href="#cite_note-pmid8582117-119" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span> It has been suggested that changes in dose should not be made with a gap of less than a week.<span class="mw-ref" id="cite_ref-pmid2248087_5-2"><a href="#cite_note-pmid2248087-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Moclobemide has good penetration across the blood brain barrier with peak plasma levels within the central nervous system occurring 2 hours after administration.<span class="mw-ref" id="cite_ref-pmid1705137_127-0"><a href="#cite_note-pmid1705137-127" style="counter-reset: mw-Ref 127;"><span class="mw-reflink-text">[127]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Animal_toxicology">Animal toxicology</h2></summary>
    
<ul><li>Acute toxicity: The oral LD<sub style="font-size:-1">50</sub> values in mouse and rat are quite high, indicating a wide therapeutic index. LD<sub>50</sub> for mice is 730<span>&nbsp;</span>mg/kg and for rats 1,300<span>&nbsp;</span>mg/kg. In dogs doses in excess of 300<span>&nbsp;</span>mg/kg led to vomiting, salivation, ataxia, and drowsiness.</li>
<li>Chronic toxicity: In an 18-months-study in rats with 10<span>&nbsp;</span>mg/kg no signs of chronic toxicity were noted, with 50<span>&nbsp;</span>mg/kg and 250<span>&nbsp;</span>mg/kg only a slight loss of weight, and with 250<span>&nbsp;</span>mg/kg mildly elevated Alkaline phosphatase and Gamma-GT. Studies in dogs revealed no toxicity relevant for humans. No evidence for a possible hepatic or cardiovascular toxicity was found.</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Irreversible MAOI antidepressants were discovered accidentally in the 1950s but their popularity declined as their toxicity especially their dangerous food interactions became apparent and rival tricyclic antidepressants were discovered. Reversible MAOIs were developed in the hope that they would exert efficacy in depressive disorders but with less of the toxicity of the older irreversible compounds; moclobemide's discovery and marketing brought the renewed interest in MAOIs due to an absence of dangerous <a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">tyramine</a> food interactions and potent antidepressant effects.<span class="mw-ref" id="cite_ref-pmid1394027_16-1"><a href="#cite_note-pmid1394027-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-pmid1609042_128-0"><a href="#cite_note-pmid1609042-128" style="counter-reset: mw-Ref 128;"><span class="mw-reflink-text">[128]</span></a></span> In 1992 moclobemide was launched onto the world markets.<span class="mw-ref" id="cite_ref-pmid7593735_129-0"><a href="#cite_note-pmid7593735-129" style="counter-reset: mw-Ref 129;"><span class="mw-reflink-text">[129]</span></a></span> Moclobemide was the first reversible MAO-A inhibitor to be widely marketed<span class="mw-ref" id="cite_ref-pmid9005342_130-0"><a href="#cite_note-pmid9005342-130" style="counter-reset: mw-Ref 130;"><span class="mw-reflink-text">[130]</span></a></span> Moclobemide as well as other newer antidepressants such as the SSRIs lead to changes in prescribing patterns and broadened the treatment options for the management of depressive disorders.<span class="mw-ref" id="cite_ref-pmid7980156_131-0"><a href="#cite_note-pmid7980156-131" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span></p>

<p>When moclobemide was discovered in 1972 in Switzerland,<span class="mw-ref" id="cite_ref-pmid10063483_12-5"><a href="#cite_note-pmid10063483-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> it was first hypothesized as being an antilipaemic or antibiotic, but the screenings were negative. The search for its antidepressant qualities, based on anticholinergic tests, also proved negative and moclobemide was then suspected of being an antipsychotic before its specific and reversible MAO-A inhibition qualities were detected. After the establishment of its lack of relevant interference with tyramine pressure response, clinical trials were launched in 1977 and further trials confirmed the broad antidepressant activity of RIMAs.<span class="mw-ref" id="cite_ref-pmid8923103_132-0"><a href="#cite_note-pmid8923103-132" style="counter-reset: mw-Ref 132;"><span class="mw-reflink-text">[132]</span></a></span> It was first approved in the UK and Europe as the first reversible and selective inhibitor of MAO-A and is now approved in over 50 countries worldwide.<span class="mw-ref" id="cite_ref-pmid10063483_12-6"><a href="#cite_note-pmid10063483-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Subsequent research found that moclobemide is well tolerated in elderly patients<span class="mw-ref" id="cite_ref-pmid9469236_133-0"><a href="#cite_note-pmid9469236-133" style="counter-reset: mw-Ref 133;"><span class="mw-reflink-text">[133]</span></a></span> and far superior to tricyclic antidepressants in terms of side effects, tolerability and overdose. With regard to effectiveness in the treatment of depression, moclobemide was determined to be as effective as all major antidepressant drug classes. There is no need for dietary restrictions in contrast to people on irreversible MAOIs and apart from an important interaction with other serotonergic enhancing agents such as SSRIs and pethidine, there are few serious drug interactions and because of these benefits, moclobemide became regarded as a beneficial addition to medical 'prescribing arsenal'.<span class="mw-ref" id="cite_ref-pmid8255982_85-1"><a href="#cite_note-pmid8255982-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span><span class="mw-ref" id="cite_ref-pmid8253702_134-0"><a href="#cite_note-pmid8253702-134" style="counter-reset: mw-Ref 134;"><span class="mw-reflink-text">[134]</span></a></span> Additionally moclobemide was found, unlike most other antidepressants on the market, to actually improve all aspects of sexual function.<span class="mw-ref" id="cite_ref-pmid9696909_135-0"><a href="#cite_note-pmid9696909-135" style="counter-reset: mw-Ref 135;"><span class="mw-reflink-text">[135]</span></a></span> It is the only reversible MAOI in use in clinical practice.<span class="mw-ref" id="cite_ref-pmid7905288_8-22"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> The fact that moclobemide's pharmacokinetic properties are unaltered by age, that cognition is improved in the elderly, and moclobemide has low potential for food and drug interactions opened up a new avenue for the treatment of major depressive disorder.<span class="mw-ref" id="cite_ref-pmid7905288_8-23"><a href="#cite_note-pmid7905288-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Due to a lack of financial incentive, such as the costs of conducting the necessary trials to gain approval, moclobemide is unavailable in the USA pharmaceutical market.<span class="mw-ref" id="cite_ref-pmid10063483_12-7"><a href="#cite_note-pmid10063483-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> In 2016 moclobemide was discontinued in Brazil for commercial reasons.<span class="mw-ref" id="cite_ref-136"><a href="#cite_note-136" style="counter-reset: mw-Ref 136;"><span class="mw-reflink-text">[136]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brands">Brands</h3></summary>
    
<p>It is sold under many trade names worldwide.<span class="mw-ref" id="cite_ref-drugs.comINTMoclobemide_137-0"><a href="#cite_note-drugs.comINTMoclobemide-137" style="counter-reset: mw-Ref 137;"><span class="mw-reflink-text">[137]</span></a></span></p>

<div style="margin-left:0">
<table class="mw-collapsible mw-collapsed " style="background: transparent; text-align: left; border: 1px solid Silver; margin: 0.2em auto auto; width:100%; clear: both; padding: 1px;">
<tbody><tr>
<th style="background: #F0F2F5; font-size:87%; padding:0.2em 0.3em; text-align:center; "><div style="display:inline;font-size:115%">Brand name listings</div></th></tr>

<tr>
<td style="border: solid 1px Silver; padding: 0.6em; background: White;">
<p>It is sold under many trade names worldwide including Apo-Moclob, Apo-Moclobemide, Auromid, Aurorix, Bei Su, Biorix, Depnil, Eutac, Hai Bei Lin, Langtian, Manerix, Mobemid, Moclamine, Moclo A, Moclobemid - 1 A Pharma, Moclobemid AL, Moclobemid HEXAL, Moclobemid ratiopharm, Moclobemida, Moclobemida Genedec, Moclobemida Teva, Moclobemide Actavis, Moclobemide Aurobindo, Moclobemide CF, Moclobemide Mylan, Moclobemide Sandoz, Moclobemide Sopharma, Moclobemide Teva, Moclobemid-neuraxpharm, Moclobemid-ratiopharm, Moclobeta, Moclod, moclodura, Moclostad, Mocrim, Modafinil Arrow, Moklar, Teva-Moclobemide, Tian Tai, Ya Zheng, and Zorix.<span class="mw-ref" id="cite_ref-drugs.comINTMoclobemide_137-1"><a href="#cite_note-drugs.comINTMoclobemide-137" style="counter-reset: mw-Ref 137;"><span class="mw-reflink-text">[137]</span></a></span></p></td></tr>

</tbody></table></div>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite id="CITEREFFittonFaulds,_DGoa,_KL1992" class="citation journal cs1">Fitton, A; Faulds, D; Goa, KL (April 1992). "Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness". <i>Drugs</i>. <b>43</b> (4): 561–596. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-199243040-00009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-199243040-00009'" tppabs="https://doi.org/10.2165%2F00003495-199243040-00009" class="external text external">10.2165/00003495-199243040-00009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1377119  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1377119'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1377119" class="external text external">1377119</a>.</cite></span></li><li id="cite_note-Lancet-2"> <span id="mw-reference-text-cite_note-Lancet-2" class="mw-reference-text"><cite id="CITEREFFreeman1993" class="citation journal cs1">Freeman, H (December 1993). "Moclobemide". <i>Lancet</i>. <b>342</b> (8886–8887): 1528–1532. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2805%2980090-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2805%2980090-X'" tppabs="https://doi.org/10.1016%2FS0140-6736%2805%2980090-X" class="external text external">10.1016/S0140-6736(05)80090-X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7902906  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7902906'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7902906" class="external text external">7902906</a>.</cite></span></li><li id="cite_note-MAOA-3"> <span id="mw-reference-text-cite_note-MAOA-3" class="mw-reference-text"><cite id="CITEREFSchoerlinMayersohn,_MKorn,_AEggers,_H1987" class="citation journal cs1">Schoerlin, MP; Mayersohn, M; Korn, A; Eggers, H (October 1987). "Disposition kinetics of moclobemide, a monoamine oxidase-A enzyme inhibitor: single and multiple dosing in normal subjects". <i>Clinical Pharmacology and Therapeutics</i>. <b>42</b> (4): 395–404. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fclpt.1987.169  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fclpt.1987.169'" tppabs="https://doi.org/10.1038%2Fclpt.1987.169" class="external text external">10.1038/clpt.1987.169</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3665338  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3665338'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3665338" class="external text external">3665338</a>.</cite></span></li><li id="cite_note-pmid2248086-4"> <span id="mw-reference-text-cite_note-pmid2248086-4" class="mw-reference-text"><cite id="CITEREFJauchGriesserOesterhelt1990" class="citation journal cs1">Jauch R, Griesser E, Oesterhelt G,  et al. (1990). "Biotransformation of moclobemide in humans". <i>Acta Psychiatr Scand Suppl</i>. <b>360</b>: 87–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1990.tb05344.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1990.tb05344.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1990.tb05344.x" class="external text external">10.1111/j.1600-0447.1990.tb05344.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2248086  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2248086'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2248086" class="external text external">2248086</a>.</cite></span></li><li id="cite_note-pmid2248087-5"> <span id="mw-reference-text-cite_note-pmid2248087-5" class="mw-reference-text"><cite id="CITEREFGuentertTuckerKornPfefen1990" class="citation journal cs1">Guentert TW, Tucker G, Korn A, Pfefen JP, Haefelfinger P, Schoerlin MP (1990). "Pharmacokinetics of moclobemide after single and multiple oral dosing with 150 milligrams 3 times daily for 15 days". <i>Acta Psychiatr Scand Suppl</i>. <b>360</b>: 91–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1990.tb05345.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1990.tb05345.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1990.tb05345.x" class="external text external">10.1111/j.1600-0447.1990.tb05345.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2248087  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2248087'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2248087" class="external text external">2248087</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFGex-FabryBalant-Gorgia,_AEBalant,_LP1995" class="citation journal cs1">Gex-Fabry, M; Balant-Gorgia, AE; Balant, LP (February 1995). "Potential of concentration monitoring data for a short half-life drug: analysis of pharmacokinetic variability for moclobemide". <i>Therapeutic Drug Monitoring</i>. <b>17</b> (1): 39–46. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00007691-199502000-00007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00007691-199502000-00007'" tppabs="https://doi.org/10.1097%2F00007691-199502000-00007" class="external text external">10.1097/00007691-199502000-00007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7725375  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7725375'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7725375" class="external text external">7725375</a>.</cite></span></li><li id="cite_note-pmid8023056-7"> <span id="mw-reference-text-cite_note-pmid8023056-7" class="mw-reference-text"><cite id="CITEREFScheen_AJ1994" class="citation journal cs1">Scheen AJ (May 1994). "[Drug of the month. Moclobemide (Aurorix)]". <i>Rev Med Liege</i> (in French). <b>49</b> (5): 291–2. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8023056  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8023056'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8023056" class="external text external">8023056</a>.</cite></span></li><li id="cite_note-pmid7905288-8"> <span id="mw-reference-text-cite_note-pmid7905288-8" class="mw-reference-text"><cite id="CITEREFNairAhmedKin1993" class="citation journal cs1">Nair NP, Ahmed SK, Kin NM (November 1993). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542" class="external text external">"Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide"</a>. <i>J Psychiatry Neurosci</i>. <b>18</b> (5): 214–25. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542" class="external text external">1188542</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7905288  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7905288'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7905288" class="external text external">7905288</a>.</cite></span></li><li id="cite_note-pmid8875133-9"> <span id="mw-reference-text-cite_note-pmid8875133-9" class="mw-reference-text"><cite id="CITEREFFultonBenfield1996" class="citation journal cs1">Fulton B, Benfield P (September 1996). "Moclobemide. An update of its pharmacological properties and therapeutic use". <i>Drugs</i>. <b>52</b> (3): 450–74. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-199652030-00013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-199652030-00013'" tppabs="https://doi.org/10.2165%2F00003495-199652030-00013" class="external text external">10.2165/00003495-199652030-00013</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8875133  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8875133'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8875133" class="external text external">8875133</a>.</cite></span></li><li id="cite_note-AMH-10"> <span id="mw-reference-text-cite_note-AMH-10" class="mw-reference-text"><cite id="CITEREFRossi,_S2013" class="citation book cs1">Rossi, S, ed. (2013). <i>Australian Medicines Handbook</i> (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. ISBN<span>&nbsp;</span><bdi>978-0-9805790-9-3</bdi>.</cite></span></li><li id="cite_note-BNF-11"> <span id="mw-reference-text-cite_note-BNF-11" class="mw-reference-text"><cite id="CITEREFJoint_Formulary_Committee2013" class="citation book cs1">Joint Formulary Committee (2013). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/bnf65britishnati0000unse  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/bnf65britishnati0000unse'" tppabs="https://archive.org/details/bnf65britishnati0000unse" class="external text external"><i>British National Formulary (BNF)</i></a></span> (65 ed.). London, UK: Pharmaceutical Press. ISBN<span>&nbsp;</span><bdi>978-0-85711-084-8</bdi>.</cite></span></li><li id="cite_note-pmid10063483-12"> <span id="mw-reference-text-cite_note-pmid10063483-12" class="mw-reference-text"><cite id="CITEREFLotufo-Neto_F.Trivedi_M.Thase_M.E.1999" class="citation journal cs1">Lotufo-Neto F.; Trivedi M.; Thase M.E. (1999). <a href="javascript:if(confirm('http://www.nature.com/npp/journal/v20/n3/pdf/1395258a.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nature.com/npp/journal/v20/n3/pdf/1395258a.pdf'" tppabs="http://www.nature.com/npp/journal/v20/n3/pdf/1395258a.pdf" class="external text external">"Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression"</a> <span class="cs1-format">(PDF)</span>. <i>Neuropsychopharmacology</i>. <b>20</b> (3): 226–247. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0893-133X%2898%2900075-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0893-133X%2898%2900075-X'" tppabs="https://doi.org/10.1016%2FS0893-133X%2898%2900075-X" class="external text external">10.1016/S0893-133X(98)00075-X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10063483  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10063483'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10063483" class="external text external">10063483</a>.</cite></span></li><li id="cite_note-SANDOZ-13"> <span id="mw-reference-text-cite_note-SANDOZ-13" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-01146-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-01146-3'" tppabs="https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-01146-3" class="external text external">"PRODUCT INFORMATION MOCLOBEMIDE SANDOZ® 150mg and 300mg TABLETS"</a>. <i>TGA eBusiness Services</i>. Sandoz. 6 March 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">16 October</span> 2013</span>.</cite></span></li><li id="cite_note-pmid9074307-14"> <span id="mw-reference-text-cite_note-pmid9074307-14" class="mw-reference-text"><cite id="CITEREFKennedy_SH1997" class="citation journal cs1">Kennedy SH (March 1997). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188835  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188835'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188835" class="external text external">"Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors"</a>. <i>J Psychiatry Neurosci</i>. <b>22</b> (2): 127–31. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188835  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188835'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188835" class="external text external">1188835</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9074307  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9074307'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9074307" class="external text external">9074307</a>.</cite></span></li><li id="cite_note-pmid1609114-15"> <span id="mw-reference-text-cite_note-pmid1609114-15" class="mw-reference-text"><cite id="CITEREFCesuraPletscher1992" class="citation book cs1">Cesura AM, Pletscher A (1992). <i>The new generation of monoamine oxidase inhibitors</i>. <i>Prog Drug Res</i>. <b>38</b>. pp.<span>&nbsp;</span>171–297. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-3-0348-7141-9_3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-3-0348-7141-9_3'" tppabs="https://doi.org/10.1007%2F978-3-0348-7141-9_3" class="external text external">10.1007/978-3-0348-7141-9_3</a>. ISBN<span>&nbsp;</span><bdi>978-3-0348-7143-3</bdi>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1609114  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1609114'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1609114" class="external text external">1609114</a>.</cite></span></li><li id="cite_note-pmid1394027-16"> <span id="mw-reference-text-cite_note-pmid1394027-16" class="mw-reference-text"><cite id="CITEREFRothGuelfi1992" class="citation journal cs1">Roth M, Guelfi JD (September 1992). "The efficacy of reversible monoamine oxidase inhibitors in depressive illness". <i>Can J Psychiatry</i>. 37 Suppl 1: 18–24. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1394027  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1394027'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1394027" class="external text external">1394027</a>.</cite></span></li><li id="cite_note-Amrein-1993-17"> <span id="mw-reference-text-cite_note-Amrein-1993-17" class="mw-reference-text"><cite id="CITEREFAmreinHetzelStablSchmid-Burgk1993" class="citation journal cs1">Amrein, R.; Hetzel, W.; Stabl, M.; Schmid-Burgk, W. (Jan 1993). "RIMA--a new concept in the treatment of depression with moclobemide". <i>Int Clin Psychopharmacol</i>. <b>7</b> (3–4): 123–32. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199300730-00001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199300730-00001'" tppabs="https://doi.org/10.1097%2F00004850-199300730-00001" class="external text external">10.1097/00004850-199300730-00001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8468432  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8468432'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8468432" class="external text external">8468432</a>.</cite></span></li><li id="cite_note-pmid7980178-18"> <span id="mw-reference-text-cite_note-pmid7980178-18" class="mw-reference-text"><cite id="CITEREFMitchellMitchell1994" class="citation journal cs1">Mitchell PB, Mitchell MS (September 1994). "The management of depression. Part 2. The place of the new antidepressants". <i>Aust Fam Physician</i>. <b>23</b> (9): 1771–3, 1776–81. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7980178  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7980178'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7980178" class="external text external">7980178</a>.</cite></span></li><li id="cite_note-pmid2248063-19"> <span id="mw-reference-text-cite_note-pmid2248063-19" class="mw-reference-text"><cite id="CITEREFLecrubierGuelfi1990" class="citation journal cs1">Lecrubier Y, Guelfi JD (1990). "Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression". <i>Acta Psychiatr Scand Suppl</i>. <b>360</b>: 18–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1990.tb05319.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1990.tb05319.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1990.tb05319.x" class="external text external">10.1111/j.1600-0447.1990.tb05319.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2248063  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2248063'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2248063" class="external text external">2248063</a>.</cite></span></li><li id="cite_note-pmid1609337-20"> <span id="mw-reference-text-cite_note-pmid1609337-20" class="mw-reference-text"><cite id="CITEREFPriestBaldwinBullockKibel1992" class="citation journal cs1">Priest RG, Baldwin DS, Bullock T, Kibel D, Smeyatsky N, Steinert J (June 1992). "Recent advances in antidepressant drugs". <i>S. Afr. Med. J</i>. Suppl: 1–4. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1609337  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1609337'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1609337" class="external text external">1609337</a>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFAngstAmrein,_RStabl,_M1995" class="citation journal cs1">Angst, J; Amrein, R; Stabl, M (August 1995). "Moclobemide and tricyclic antidepressants in severe depression: meta-analysis and prospective studies". <i>Journal of Clinical Psychopharmacology</i>. <b>15</b> (4 Suppl 2): 16S–23S. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004714-199508001-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004714-199508001-00004'" tppabs="https://doi.org/10.1097%2F00004714-199508001-00004" class="external text external">10.1097/00004714-199508001-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7593725  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7593725'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7593725" class="external text external">7593725</a>.</cite></span></li><li id="cite_note-pmid7717094-22"> <span id="mw-reference-text-cite_note-pmid7717094-22" class="mw-reference-text"><cite id="CITEREFPriest,_RGGimbrett,_RRoberts,_MSteinert,_J1995" class="citation journal cs1">Priest, RG; Gimbrett, R; Roberts, M; Steinert, J (1995). "Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders". <i>Acta Psychiatr Scand Suppl</i>. <b>386</b>: 40–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1995.tb05923.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1995.tb05923.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1995.tb05923.x" class="external text external">10.1111/j.1600-0447.1995.tb05923.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7717094  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7717094'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7717094" class="external text external">7717094</a>.</cite></span></li><li id="cite_note-pmid8440808-23"> <span id="mw-reference-text-cite_note-pmid8440808-23" class="mw-reference-text"><cite id="CITEREFSpoovSuominenLahdelma1993" class="citation journal cs1">Spoov J, Suominen JY, Lahdelma RL,  et al. (February 1993). "Do reversed depressive symptoms occur together as a syndrome?". <i>J Affect Disord</i>. <b>27</b> (2): 131–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0165-0327%2893%2990086-Y  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0165-0327%2893%2990086-Y'" tppabs="https://doi.org/10.1016%2F0165-0327%2893%2990086-Y" class="external text external">10.1016/0165-0327(93)90086-Y</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8440808  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8440808'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8440808" class="external text external">8440808</a>.</cite></span></li><li id="cite_note-Angst-1993-24"> <span id="mw-reference-text-cite_note-Angst-1993-24" class="mw-reference-text"><cite id="CITEREFAngstScheideggerStabl1993" class="citation journal cs1">Angst, J.; Scheidegger, P.; Stabl, M. (1993). "Efficacy of moclobemide in different patient groups. Results of new subscales of the Hamilton Depression Rating Scale". <i>Clin Neuropharmacol</i>. 16 Suppl 2: S55–62. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8313398  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8313398'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8313398" class="external text external">8313398</a>.</cite></span></li><li id="cite_note-Woggon-1993-25"> <span id="mw-reference-text-cite_note-Woggon-1993-25" class="mw-reference-text"><cite id="CITEREFWoggon1993" class="citation journal cs1">Woggon, B. (Jan 1993). "The role of moclobemide in endogenous depression: a survey of recent data". <i>Int Clin Psychopharmacol</i>. <b>7</b> (3–4): 137–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199300730-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199300730-00003'" tppabs="https://doi.org/10.1097%2F00004850-199300730-00003" class="external text external">10.1097/00004850-199300730-00003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8468434  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8468434'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8468434" class="external text external">8468434</a>.</cite></span></li><li id="cite_note-Silverstone-1993-26"> <span id="mw-reference-text-cite_note-Silverstone-1993-26" class="mw-reference-text"><cite id="CITEREFSilverstone1993" class="citation journal cs1">Silverstone, T. (Jan 1993). "Moclobemide--placebo-controlled trials". <i>Int Clin Psychopharmacol</i>. <b>7</b> (3–4): 133–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199300730-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199300730-00002'" tppabs="https://doi.org/10.1097%2F00004850-199300730-00002" class="external text external">10.1097/00004850-199300730-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8468433  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8468433'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8468433" class="external text external">8468433</a>.</cite></span></li><li id="cite_note-pmid8468436-27"> <span id="mw-reference-text-cite_note-pmid8468436-27" class="mw-reference-text"><cite id="CITEREFPhilippKohnenBenkert1993" class="citation journal cs1">Philipp M, Kohnen R, Benkert O (January 1993). "A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction". <i>Int Clin Psychopharmacol</i>. <b>7</b> (3–4): 149–53. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199300730-00005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199300730-00005'" tppabs="https://doi.org/10.1097%2F00004850-199300730-00005" class="external text external">10.1097/00004850-199300730-00005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8468436  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8468436'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8468436" class="external text external">8468436</a>.</cite></span></li><li id="cite_note-pmid8353831-28"> <span id="mw-reference-text-cite_note-pmid8353831-28" class="mw-reference-text"><cite id="CITEREFTikalHrabánková1993" class="citation journal cs1">Tikal K, Hrabánková M (June 1993). "[Indications for antidepressive agents in relation to diseases of the cardiovascular system]". <i>Cesk Psychiatr</i> (in Czech). <b>89</b> (3): 163–5. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8353831  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8353831'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8353831" class="external text external">8353831</a>.</cite></span></li><li id="cite_note-pmid8557884-29"> <span id="mw-reference-text-cite_note-pmid8557884-29" class="mw-reference-text"><cite id="CITEREFDelini-StulaMikkelsenAngst1995" class="citation journal cs1">Delini-Stula A, Mikkelsen H, Angst J (October 1995). "Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies". <i>J Affect Disord</i>. <b>35</b> (1–2): 21–30. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0165-0327%2895%2900034-K  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0165-0327%2895%2900034-K'" tppabs="https://doi.org/10.1016%2F0165-0327%2895%2900034-K" class="external text external">10.1016/0165-0327(95)00034-K</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8557884  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8557884'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8557884" class="external text external">8557884</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFVersianiOggeroAlterwainCapponi1989" class="citation journal cs1">Versiani, M.; Oggero, U.; Alterwain, P.; Capponi, R.; Dajas, F.; Heinze-Martin, G.; Marquez, C. A.; Poleo, M. A.; Rivero-Almanzor, L. E. (1989). "A double-blind comparative trial of moclobemide v. imipramine and placebo in major depressive episodes". <i>The British Journal of Psychiatry. Supplement</i> (6): 72–77. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0960-5371  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0960-5371'" tppabs="https://www.worldcat.org/issn/0960-5371" class="external text external">0960-5371</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2695129  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2695129'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2695129" class="external text external">2695129</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFBaumhacklBizièreFischbachGeretsegger1989" class="citation journal cs1">Baumhackl, U.; Bizière, K.; Fischbach, R.; Geretsegger, C.; Hebenstreit, G.; Radmayr, E.; Stabl, M. (1989). "Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study". <i>The British Journal of Psychiatry. Supplement</i> (6): 78–83. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0960-5371  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0960-5371'" tppabs="https://www.worldcat.org/issn/0960-5371" class="external text external">0960-5371</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2695130  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2695130'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2695130" class="external text external">2695130</a>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite id="CITEREFStablBiziéreSchmid-BurgkAmrein1989" class="citation journal cs1">Stabl, M.; Biziére, K.; Schmid-Burgk, W.; Amrein, R. (1989). "Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states". <i>Journal of Neural Transmission. Supplementum</i>. <b>28</b>: 77–89. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0303-6995  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0303-6995'" tppabs="https://www.worldcat.org/issn/0303-6995" class="external text external">0303-6995</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2677244  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2677244'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2677244" class="external text external">2677244</a>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFAmreinStablHenauerAffolter1997" class="citation journal cs1">Amrein, Roman; Stabl, Max; Henauer, Stephan; Affolter, Eva; Jonkanski, Iris (1997-12-01). "Efficacy and Tolerability of Moclobemide in Comparison with Placebo, Tricyclic Antidepressants, and Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients: A Clinical Overview". <i>The Canadian Journal of Psychiatry</i>. <b>42</b> (10): 1043–1050. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F070674379704201005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F070674379704201005'" tppabs="https://doi.org/10.1177%2F070674379704201005" class="external text external">10.1177/070674379704201005</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0706-7437  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0706-7437'" tppabs="https://www.worldcat.org/issn/0706-7437" class="external text external">0706-7437</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9469236  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9469236'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9469236" class="external text external">9469236</a>.</cite></span></li><li id="cite_note-BPD-34"> <span id="mw-reference-text-cite_note-BPD-34" class="mw-reference-text"><cite id="CITEREFSilverstone,_T2001" class="citation journal cs1">Silverstone, T (August 2001). "Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial". <i>Acta Psychiatrica Scandinavica</i>. <b>104</b> (2): 104–109. doi:<a href="javascript:if(confirm('https://doi.org/10.1034%2Fj.1600-0447.2001.00240.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1034%2Fj.1600-0447.2001.00240.x'" tppabs="https://doi.org/10.1034%2Fj.1600-0447.2001.00240.x" class="external text external">10.1034/j.1600-0447.2001.00240.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11473503  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11473503'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11473503" class="external text external">11473503</a>.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite id="CITEREFMallingerFrank,_EThase,_MEBarwell,_MM2009" class="citation journal cs1">Mallinger, AG; Frank, E; Thase, ME; Barwell, MM; Diazgranados, N; Luckenbaugh, DA; Kupfer, DJ (2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570273  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570273'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570273" class="external text external">"Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?"</a>. <i>Psychopharmacology Bulletin</i>. <b>42</b> (4): 64–74. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570273  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570273'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570273" class="external text external">3570273</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19629023  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19629023'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19629023" class="external text external">19629023</a>.</cite></span></li><li id="cite_note-pmid19698626-36"> <span id="mw-reference-text-cite_note-pmid19698626-36" class="mw-reference-text"><cite id="CITEREFVersianiNardiFigueira1998" class="citation journal cs1">Versiani M, Nardi AE, Figueira I (July 1998). "Pharmacotherapy of dysthymia: review and new findings". <i>Eur. Psychiatry</i>. <b>13</b> (4): 203–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0924-9338%2898%2980005-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0924-9338%2898%2980005-9'" tppabs="https://doi.org/10.1016%2FS0924-9338%2898%2980005-9" class="external text external">10.1016/S0924-9338(98)80005-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19698626  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19698626'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19698626" class="external text external">19698626</a>.</cite></span></li><li id="cite_note-pmid8923114-37"> <span id="mw-reference-text-cite_note-pmid8923114-37" class="mw-reference-text"><cite id="CITEREFNuttMontgomery1996" class="citation journal cs1">Nutt D, Montgomery SA (June 1996). "Moclobemide in the treatment of social phobia". <i>Int Clin Psychopharmacol</i>. 11 Suppl 3 (3): 77–82. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199606000-00013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199606000-00013'" tppabs="https://doi.org/10.1097%2F00004850-199606000-00013" class="external text external">10.1097/00004850-199606000-00013</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8923114  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8923114'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8923114" class="external text external">8923114</a>.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite id="CITEREFBlancoBragdonSchneierLiebowitz2012" class="citation journal cs1">Blanco, C.; Bragdon, L. B.; Schneier, F. R.; Liebowitz, M. R. (2012). <a href="javascript:if(confirm('https://doi.org/10.1017/S1461145712000119  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1017/S1461145712000119'" tppabs="https://doi.org/10.1017/S1461145712000119" class="external text external">"The evidence-based pharmacotherapy of social anxiety disorder"</a>. <i>The International Journal of Neuropsychopharmacology</i>. <b>16</b> (1): 235–249. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1017%2FS1461145712000119  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1017%2FS1461145712000119'" tppabs="https://doi.org/10.1017%2FS1461145712000119" class="external text external">10.1017/S1461145712000119</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22436306  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22436306'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22436306" class="external text external">22436306</a>.</cite></span></li><li id="cite_note-pmid1393304-39"> <span id="mw-reference-text-cite_note-pmid1393304-39" class="mw-reference-text"><cite id="CITEREFVersianiNardiMundimAlves1992" class="citation journal cs1">Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R (September 1992). "Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine". <i>Br J Psychiatry</i>. <b>161</b> (3): 353–60. doi:<a href="javascript:if(confirm('https://doi.org/10.1192%2Fbjp.161.3.353  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1192%2Fbjp.161.3.353'" tppabs="https://doi.org/10.1192%2Fbjp.161.3.353" class="external text external">10.1192/bjp.161.3.353</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1393304  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1393304'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1393304" class="external text external">1393304</a>.</cite></span></li><li id="cite_note-pmid9466158-40"> <span id="mw-reference-text-cite_note-pmid9466158-40" class="mw-reference-text"><cite id="CITEREFVersianiAmreinMontgomery1997" class="citation journal cs1">Versiani M, Amrein R, Montgomery SA (September 1997). "Social phobia: long-term treatment outcome and prediction of response--a moclobemide study". <i>Int Clin Psychopharmacol</i>. <b>12</b> (5): 239–54. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199709000-00001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199709000-00001'" tppabs="https://doi.org/10.1097%2F00004850-199709000-00001" class="external text external">10.1097/00004850-199709000-00001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9466158  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9466158'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9466158" class="external text external">9466158</a>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text">Udo Bonnet. Department of Psychiatry and Psychotherapy, University of Essen, Essen, Germany. "Moclobemide: Therapeutic Use and Clinical Studies". 114-116.</span></li><li id="cite_note-Berlin-1995-42"> <span id="mw-reference-text-cite_note-Berlin-1995-42" class="mw-reference-text"><cite id="CITEREFBerlinSaïdSpreux-VaroquauxLaunay1995" class="citation journal cs1">Berlin, I.; Saïd, S.; Spreux-Varoquaux, O.; Launay, JM.; Olivares, R.; Millet, V.; Lecrubier, Y.; Puech, AJ. (Oct 1995). "A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers". <i>Clin Pharmacol Ther</i>. <b>58</b> (4): 444–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0009-9236%2895%2990058-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0009-9236%2895%2990058-6'" tppabs="https://doi.org/10.1016%2F0009-9236%2895%2990058-6" class="external text external">10.1016/0009-9236(95)90058-6</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7586937  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7586937'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7586937" class="external text external">7586937</a>.</cite></span></li><li id="cite_note-Hughes-2007-43"> <span id="mw-reference-text-cite_note-Hughes-2007-43" class="mw-reference-text"><cite id="CITEREFHughesSteadLancaster2007" class="citation journal cs1">Hughes, JR.; Stead, LF.; Lancaster, T. (2007).  Hughes, John R (ed.). "Antidepressants for smoking cessation". <i>Cochrane Database Syst Rev</i> (1): CD000031. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD000031.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD000031.pub3'" tppabs="https://doi.org/10.1002%2F14651858.CD000031.pub3" class="external text external">10.1002/14651858.CD000031.pub3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17253443  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17253443'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17253443" class="external text external">17253443</a>.</cite></span></li><li id="cite_note-pmid9466172-44"> <span id="mw-reference-text-cite_note-pmid9466172-44" class="mw-reference-text"><cite id="CITEREFTillerBouwerBehnke1997" class="citation journal cs1">Tiller JW, Bouwer C, Behnke K (October 1997). "Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder". <i>Int Clin Psychopharmacol</i>. 12 Suppl 6: S27–30. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199710006-00006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199710006-00006'" tppabs="https://doi.org/10.1097%2F00004850-199710006-00006" class="external text external">10.1097/00004850-199710006-00006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9466172  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9466172'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9466172" class="external text external">9466172</a>.</cite></span></li><li id="cite_note-Heymann--45"> <span id="mw-reference-text-cite_note-Heymann--45" class="mw-reference-text"><cite id="CITEREFHeymannPaivaHelfensteinPollak2010" class="citation journal cs1">Heymann, RE.; Paiva, Edos S.; Helfenstein, M.; Pollak, DF.; Martinez, JE.; Provenza, JR.; Paula, AP.; Althoff, AC.; Souza, EJ.; Neubarth, Fernando; Lage, Lais Verderame; Rezende, Marcelo Cruz; Assis, Marcos Renato de; Lopes, Maria Lucia Lemos; Jennings, Fabio; Araújo, Rejane Leal C. da Costa; Cristo, Valéria Valim; Costa, Evelin Diana Goldenberg; Kaziyama, Helena Hideko S.; Yeng, Lin Tchia; Iamamura, Marta; Saron, Thais Rodrigues Pato; Nascimento, Osvaldo J. M.; Kimura, Luiz Koiti; Leite, Vilnei Mattioli; Oliveira, Juliano; Araújo, Gabriela Tannus Branco de; Fonseca, Marcelo Cunio Machado (2010). <a href="javascript:if(confirm('https://doi.org/10.1590/S0482-50042010000100006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1590/S0482-50042010000100006'" tppabs="https://doi.org/10.1590/S0482-50042010000100006" class="external text external">"Brazilian consensus on the treatment of fibromyalgia"</a>. <i>Rev Bras Reumatol</i>. <b>50</b> (1): 56–66. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1590%2FS0482-50042010000100006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1590%2FS0482-50042010000100006'" tppabs="https://doi.org/10.1590%2FS0482-50042010000100006" class="external text external">10.1590/S0482-50042010000100006</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21125141  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21125141'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21125141" class="external text external">21125141</a>.</cite></span></li><li id="cite_note-pmid8349478-46"> <span id="mw-reference-text-cite_note-pmid8349478-46" class="mw-reference-text"><cite id="CITEREFClaman_JM1993" class="citation journal cs1">Claman JM (June 1993). "The potential effectiveness of moclobemide, the new monoamine oxidase inhibitor, in the prophylaxis of migraine". <i>Headache</i>. <b>33</b> (6): 339. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1526-4610.1993.hed3306339.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1526-4610.1993.hed3306339.x'" tppabs="https://doi.org/10.1111%2Fj.1526-4610.1993.hed3306339.x" class="external text external">10.1111/j.1526-4610.1993.hed3306339.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8349478  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8349478'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8349478" class="external text external">8349478</a>.</cite></span></li><li id="cite_note-pmid9324719-47"> <span id="mw-reference-text-cite_note-pmid9324719-47" class="mw-reference-text"><cite id="CITEREFMeienbergAmsler1997" class="citation journal cs1">Meienberg O, Amsler F (July 1997). "[Preventive treatment of migraine and chronic tension headache with moclobemide]". <i>Praxis (Bern 1994)</i> (in German). <b>86</b> (27–28): 1107–12. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9324719  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9324719'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9324719" class="external text external">9324719</a>.</cite></span></li><li id="cite_note-pmid2248064-48"> <span id="mw-reference-text-cite_note-pmid2248064-48" class="mw-reference-text"><cite id="CITEREFLiebowitzHollanderSchneier1990" class="citation journal cs1">Liebowitz MR, Hollander E, Schneier F,  et al. (1990). "Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders". <i>Acta Psychiatr Scand Suppl</i>. <b>360</b>: 29–34. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1990.tb05321.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1990.tb05321.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1990.tb05321.x" class="external text external">10.1111/j.1600-0447.1990.tb05321.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2248064  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2248064'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2248064" class="external text external">2248064</a>.</cite></span></li><li id="cite_note-pmid7915384-49"> <span id="mw-reference-text-cite_note-pmid7915384-49" class="mw-reference-text"><cite id="CITEREFMenkesThomasPhipps1994" class="citation journal cs1">Menkes DB, Thomas MC, Phipps RF (September 1994). "Moclobemide for menopausal flushing". <i>Lancet</i>. <b>344</b> (8923): 691–2. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2894%2992131-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2894%2992131-8'" tppabs="https://doi.org/10.1016%2FS0140-6736%2894%2992131-8" class="external text external">10.1016/S0140-6736(94)92131-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7915384  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7915384'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7915384" class="external text external">7915384</a>.</cite></span></li><li id="cite_note-pmid7593732-50"> <span id="mw-reference-text-cite_note-pmid7593732-50" class="mw-reference-text"><cite id="CITEREFSieradzanChannonRamponiStern1995" class="citation journal cs1">Sieradzan K, Channon S, Ramponi C, Stern GM, Lees AJ, Youdim MB (August 1995). "The therapeutic potential of moclobemide, a reversible selective monoamine oxidase A inhibitor in Parkinson's disease". <i>J Clin Psychopharmacol</i>. <b>15</b> (4 Suppl 2): 51S–59S. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004714-199508001-00010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004714-199508001-00010'" tppabs="https://doi.org/10.1097%2F00004714-199508001-00010" class="external text external">10.1097/00004714-199508001-00010</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7593732  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7593732'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7593732" class="external text external">7593732</a>.</cite></span></li><li id="cite_note-pmid8968657-51"> <span id="mw-reference-text-cite_note-pmid8968657-51" class="mw-reference-text"><cite id="CITEREFBaumann_P1996" class="citation journal cs1">Baumann P (December 1996). "Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors". <i>Clin Pharmacokinet</i>. <b>31</b> (6): 444–69. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-199631060-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-199631060-00004'" tppabs="https://doi.org/10.2165%2F00003088-199631060-00004" class="external text external">10.2165/00003088-199631060-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8968657  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8968657'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8968657" class="external text external">8968657</a>.</cite></span></li><li id="cite_note-pmid1546140-52"> <span id="mw-reference-text-cite_note-pmid1546140-52" class="mw-reference-text"><cite id="CITEREFHillYauWhitwam1992" class="citation journal cs1">Hill S, Yau K, Whitwam J (1992). "MAOIs to RIMAs in anaesthesia--a literature review". <i>Psychopharmacology</i>. 106 Suppl: S43–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02246234  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02246234'" tppabs="https://doi.org/10.1007%2Fbf02246234" class="external text external">10.1007/bf02246234</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1546140  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1546140'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1546140" class="external text external">1546140</a>.</cite></span></li><li id="cite_note-Blom-Peters-1993-53"> <span id="mw-reference-text-cite_note-Blom-Peters-1993-53" class="mw-reference-text"><cite id="CITEREFBlom-PetersLamy1993" class="citation journal cs1">Blom-Peters, L.; Lamy, M. (1993). "Monoamine oxidase inhibitors and anesthesia: an updated literature review". <i>Acta Anaesthesiol Belg</i>. <b>44</b> (2): 57–60. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8237297  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8237297'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8237297" class="external text external">8237297</a>.</cite></span></li><li id="cite_note-pmid8488751-54"> <span id="mw-reference-text-cite_note-pmid8488751-54" class="mw-reference-text"><cite id="CITEREFAlevizosHatzimanolisMarkianosStefanis1993" class="citation journal cs1">Alevizos B, Hatzimanolis J, Markianos M, Stefanis CN (April 1993). "Clinical, endocrine and neurochemical effects of moclobemide in depressed patients". <i>Acta Psychiatr Scand</i>. <b>87</b> (4): 285–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1993.tb03373.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1993.tb03373.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1993.tb03373.x" class="external text external">10.1111/j.1600-0447.1993.tb03373.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8488751  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8488751'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8488751" class="external text external">8488751</a>.</cite></span></li><li id="cite_note-pmid1546130-55"> <span id="mw-reference-text-cite_note-pmid1546130-55" class="mw-reference-text"><cite id="CITEREFChan-Palay_V1992" class="citation journal cs1">Chan-Palay V (1992). "Depression and senile dementia of the Alzheimer type: a role for moclobemide". <i>Psychopharmacology</i>. 106 Suppl: S137–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02246259  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02246259'" tppabs="https://doi.org/10.1007%2Fbf02246259" class="external text external">10.1007/bf02246259</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1546130  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1546130'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1546130" class="external text external">1546130</a>.</cite></span></li><li id="cite_note-pmid2248077-56"> <span id="mw-reference-text-cite_note-pmid2248077-56" class="mw-reference-text"><cite id="CITEREFDe_Vanna,_MKummer,_JAgnoli,_AGentili,_P1990" class="citation journal cs1">De Vanna, M; Kummer, J; Agnoli, A; Gentili, P; Lorizio, A; Anand, R (1990). "Moclobemide compared with second-generation antidepressants in elderly people". <i>Acta Psychiatr Scand Suppl</i>. <b>360</b>: 64–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1990.tb05335.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1990.tb05335.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1990.tb05335.x" class="external text external">10.1111/j.1600-0447.1990.tb05335.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2248077  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2248077'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2248077" class="external text external">2248077</a>.</cite></span></li><li id="cite_note-pmid1546128-57"> <span id="mw-reference-text-cite_note-pmid1546128-57" class="mw-reference-text"><cite id="CITEREFTiller_JW1992" class="citation journal cs1">Tiller JW (1992). "Post-stroke depression". <i>Psychopharmacology</i>. 106 Suppl: S130–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02246257  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02246257'" tppabs="https://doi.org/10.1007%2Fbf02246257" class="external text external">10.1007/bf02246257</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1546128  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1546128'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1546128" class="external text external">1546128</a>.</cite></span></li><li id="cite_note-pmid2248080-58"> <span id="mw-reference-text-cite_note-pmid2248080-58" class="mw-reference-text"><cite id="CITEREFWesnesAnandLorscheid1990" class="citation journal cs1">Wesnes K, Anand R, Lorscheid T (1990). "Potential of moclobemide to improve cerebral insufficiency identified using a scopolamine model of aging and dementia". <i>Acta Psychiatr Scand Suppl</i>. <b>360</b>: 71–2. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1990.tb05338.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1990.tb05338.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1990.tb05338.x" class="external text external">10.1111/j.1600-0447.1990.tb05338.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2248080  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2248080'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2248080" class="external text external">2248080</a>.</cite></span></li><li id="cite_note-pmid7593736-59"> <span id="mw-reference-text-cite_note-pmid7593736-59" class="mw-reference-text"><cite id="CITEREFGuentertBankenHiltonHolford1995" class="citation journal cs1">Guentert TW, Banken L, Hilton S, Holford NH (August 1995). "Moclobemide: relationships between dose, drug concentration in plasma, and occurrence of adverse events". <i>J Clin Psychopharmacol</i>. <b>15</b> (4 Suppl 2): 84S–94S. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004714-199508001-00014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004714-199508001-00014'" tppabs="https://doi.org/10.1097%2F00004714-199508001-00014" class="external text external">10.1097/00004714-199508001-00014</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7593736  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7593736'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7593736" class="external text external">7593736</a>.</cite></span></li><li id="cite_note-pmid7622819-60"> <span id="mw-reference-text-cite_note-pmid7622819-60" class="mw-reference-text"><cite id="CITEREFSwinkelsde_Jonghe1995" class="citation journal cs1">Swinkels JA, de Jonghe F (January 1995). "Safety of antidepressants". <i>Int Clin Psychopharmacol</i>. 9 Suppl 4: 19–25. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199501004-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199501004-00003'" tppabs="https://doi.org/10.1097%2F00004850-199501004-00003" class="external text external">10.1097/00004850-199501004-00003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7622819  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7622819'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7622819" class="external text external">7622819</a>.</cite></span></li><li id="cite_note-pmid7954486-61"> <span id="mw-reference-text-cite_note-pmid7954486-61" class="mw-reference-text"><cite id="CITEREFMollNeumannSchmid-BurgkStabl1994" class="citation journal cs1">Moll E, Neumann N, Schmid-Burgk W, Stabl M, Amrein R (1994). "Safety and efficacy during long-term treatment with moclobemide". <i>Clin Neuropharmacol</i>. 17 Suppl 1: S74–87. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00002826-199417001-00009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00002826-199417001-00009'" tppabs="https://doi.org/10.1097%2F00002826-199417001-00009" class="external text external">10.1097/00002826-199417001-00009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7954486  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7954486'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7954486" class="external text external">7954486</a>.</cite></span></li><li id="cite_note-pmid8144126-62"> <span id="mw-reference-text-cite_note-pmid8144126-62" class="mw-reference-text"><cite id="CITEREFBaierPhilipp1994" class="citation journal cs1">Baier D, Philipp M (January 1994). "[Modification of sexual functions by antidepressants]". <i>Fortschr Neurol Psychiatr</i> (in German). <b>62</b> (1): 14–21. doi:<a href="javascript:if(confirm('https://doi.org/10.1055%2Fs-2007-996652  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1055%2Fs-2007-996652'" tppabs="https://doi.org/10.1055%2Fs-2007-996652" class="external text external">10.1055/s-2007-996652</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8144126  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8144126'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8144126" class="external text external">8144126</a>.</cite></span></li><li id="cite_note-pmid8174512-63"> <span id="mw-reference-text-cite_note-pmid8174512-63" class="mw-reference-text"><cite id="CITEREFAmado-BoccaraGougoulisPoirier-LittréGalinowski1994" class="citation journal cs1">Amado-Boccara I, Gougoulis N, Poirier-Littré MF, Galinowski A, Lôo H (1994). "[Effects of antidepressants on cognitive functions. Review of the literature]". <i>Encephale</i> (in French). <b>20</b> (1): 65–77. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8174512  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8174512'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8174512" class="external text external">8174512</a>.</cite></span></li><li id="cite_note-pmid1377119-64"> <span id="mw-reference-text-cite_note-pmid1377119-64" class="mw-reference-text"><cite id="CITEREFFittonFauldsGoa1992" class="citation journal cs1">Fitton A, Faulds D, Goa KL (April 1992). "Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness". <i>Drugs</i>. <b>43</b> (4): 561–96. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-199243040-00009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-199243040-00009'" tppabs="https://doi.org/10.2165%2F00003495-199243040-00009" class="external text external">10.2165/00003495-199243040-00009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1377119  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1377119'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1377119" class="external text external">1377119</a>.</cite></span></li><li id="cite_note-pmid2123366-65"> <span id="mw-reference-text-cite_note-pmid2123366-65" class="mw-reference-text"><cite id="CITEREFVersianiNardiFigueiraStabl1990" class="citation journal cs1">Versiani M, Nardi AE, Figueira IL, Stabl M (1990). "Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo". <i>Acta Psychiatr Scand Suppl</i>. <b>360</b>: 24–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1990.tb05320.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1990.tb05320.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1990.tb05320.x" class="external text external">10.1111/j.1600-0447.1990.tb05320.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2123366  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2123366'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2123366" class="external text external">2123366</a>.</cite></span></li><li id="cite_note-pmid1394030-66"> <span id="mw-reference-text-cite_note-pmid1394030-66" class="mw-reference-text"><cite id="CITEREFAmreinHetzelStablSchmid-Burgk1992" class="citation journal cs1">Amrein R, Hetzel W, Stabl M, Schmid-Burgk W (September 1992). "RIMA: a safe concept in the treatment of depression with moclobemide". <i>Can J Psychiatry</i>. 37 Suppl 1: 7–11. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1394030  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1394030'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1394030" class="external text external">1394030</a>.</cite></span></li><li id="cite_note-pmid7741983-67"> <span id="mw-reference-text-cite_note-pmid7741983-67" class="mw-reference-text"><cite id="CITEREFNormanBurrows1995" class="citation journal cs1">Norman TR, Burrows GD (January 1995). "A risk-benefit assessment of moclobemide in the treatment of depressive disorders". <i>Drug Saf</i>. <b>12</b> (1): 46–54. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00002018-199512010-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00002018-199512010-00004'" tppabs="https://doi.org/10.2165%2F00002018-199512010-00004" class="external text external">10.2165/00002018-199512010-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7741983  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7741983'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7741983" class="external text external">7741983</a>.</cite></span></li><li id="cite_note-pmid2248062-68"> <span id="mw-reference-text-cite_note-pmid2248062-68" class="mw-reference-text"><cite id="CITEREFTiller_JW1990" class="citation journal cs1">Tiller JW (1990). "Antidepressants, alcohol and psychomotor performance". <i>Acta Psychiatr Scand Suppl</i>. <b>360</b>: 13–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1990.tb05318.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1990.tb05318.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1990.tb05318.x" class="external text external">10.1111/j.1600-0447.1990.tb05318.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2248062  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2248062'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2248062" class="external text external">2248062</a>.</cite></span></li><li id="cite_note-pmid1546141-69"> <span id="mw-reference-text-cite_note-pmid1546141-69" class="mw-reference-text"><cite id="CITEREFHindmarchKerr1992" class="citation journal cs1">Hindmarch I, Kerr J (1992). "Behavioural toxicity of antidepressants with particular reference to moclobemide". <i>Psychopharmacology</i>. 106 Suppl: S49–55. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02246236  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02246236'" tppabs="https://doi.org/10.1007%2Fbf02246236" class="external text external">10.1007/bf02246236</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1546141  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1546141'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1546141" class="external text external">1546141</a>.</cite></span></li><li id="cite_note-pmid1630391-70"> <span id="mw-reference-text-cite_note-pmid1630391-70" class="mw-reference-text"><cite id="CITEREFAldermanCallaryKent1992" class="citation journal cs1">Alderman CP, Callary JA, Kent AL (July 1992). "Peripheral oedema associated with moclobemide". <i>Med. J. Aust</i>. <b>157</b> (2): 144. doi:<a href="javascript:if(confirm('https://doi.org/10.5694%2Fj.1326-5377.1992.tb137069.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5694%2Fj.1326-5377.1992.tb137069.x'" tppabs="https://doi.org/10.5694%2Fj.1326-5377.1992.tb137069.x" class="external text external">10.5694/j.1326-5377.1992.tb137069.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1630391  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1630391'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1630391" class="external text external">1630391</a>.</cite></span></li><li id="cite_note-pmid7593727-71"> <span id="mw-reference-text-cite_note-pmid7593727-71" class="mw-reference-text"><cite id="CITEREFTillerJohnsonBurrows1995" class="citation journal cs1">Tiller JW, Johnson GF, Burrows GD (August 1995). "Moclobemide for depression: an Australian psychiatric practice study". <i>J Clin Psychopharmacol</i>. <b>15</b> (4 Suppl 2): 31S–34S. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004714-199508001-00006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004714-199508001-00006'" tppabs="https://doi.org/10.1097%2F00004714-199508001-00006" class="external text external">10.1097/00004714-199508001-00006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7593727  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7593727'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7593727" class="external text external">7593727</a>.</cite></span></li><li id="cite_note-Rimón-1993-72"> <span id="mw-reference-text-cite_note-Rimón-1993-72" class="mw-reference-text"><cite id="CITEREFRimónJääskeläinenKaartinenKalli1993" class="citation journal cs1">Rimón, R.; Jääskeläinen, J.; Kaartinen, P.; Kalli, A.; Kilponen, E.; Koskinen, T.; Nikkilä, H.; Pirttiperä, V.; Seppälä, J. (Jan 1993). "Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study". <i>Int Clin Psychopharmacol</i>. <b>7</b> (3–4): 141–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199300730-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199300730-00004'" tppabs="https://doi.org/10.1097%2F00004850-199300730-00004" class="external text external">10.1097/00004850-199300730-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8468435  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8468435'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8468435" class="external text external">8468435</a>.</cite></span></li><li id="cite_note-pmid8354766-73"> <span id="mw-reference-text-cite_note-pmid8354766-73" class="mw-reference-text"><cite class="citation journal cs1">"Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group". <i>J Affect Disord</i>. <b>28</b> (2): 105–16. June 1993. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0165-0327%2893%2990039-M  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0165-0327%2893%2990039-M'" tppabs="https://doi.org/10.1016%2F0165-0327%2893%2990039-M" class="external text external">10.1016/0165-0327(93)90039-M</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8354766  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8354766'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8354766" class="external text external">8354766</a>.</cite></span></li><li id="cite_note-pmid7941097-74"> <span id="mw-reference-text-cite_note-pmid7941097-74" class="mw-reference-text"><cite id="CITEREFGram_LF1994" class="citation journal cs1">Gram LF (September 1994). "[Antidepressive drug therapy, suicidal ideation and suicide, 2 cases reported in connection with moclobemide (Aurorix) therapy]". <i>Ugeskrift for Læger</i> (in Danish). <b>156</b> (38): 5542. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7941097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7941097'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7941097" class="external text external">7941097</a>.</cite></span></li><li id="cite_note-pmid9272192-75"> <span id="mw-reference-text-cite_note-pmid9272192-75" class="mw-reference-text"><cite id="CITEREFIsacssonHolmgrenDruidBergman1997" class="citation journal cs1">Isacsson G, Holmgren P, Druid H, Bergman U (August 1997). "The utilization of antidepressants--a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992-1994". <i>Acta Psychiatr Scand</i>. <b>96</b> (2): 94–100. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1997.tb09912.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1997.tb09912.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1997.tb09912.x" class="external text external">10.1111/j.1600-0447.1997.tb09912.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9272192  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9272192'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9272192" class="external text external">9272192</a>.</cite></span></li><li id="cite_note-pmid9512919-76"> <span id="mw-reference-text-cite_note-pmid9512919-76" class="mw-reference-text"><cite id="CITEREFCurrande_Pauw1998" class="citation journal cs1">Curran S, de Pauw K (February 1998). "Selecting an antidepressant for use in a patient with epilepsy. Safety considerations". <i>Drug Saf</i>. <b>18</b> (2): 125–33. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00002018-199818020-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00002018-199818020-00004'" tppabs="https://doi.org/10.2165%2F00002018-199818020-00004" class="external text external">10.2165/00002018-199818020-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9512919  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9512919'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9512919" class="external text external">9512919</a>.</cite></span></li><li id="cite_note-pmid7954487-77"> <span id="mw-reference-text-cite_note-pmid7954487-77" class="mw-reference-text"><cite id="CITEREFBisserbeLépine1994" class="citation journal cs1">Bisserbe JC, Lépine JP (1994). "Moclobemide in social phobia: a pilot open study. GRP Group. Groupe de Recherche en Psychopharmacologie". <i>Clin Neuropharmacol</i>. 17 Suppl 1: S88–94. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00002826-199417001-00010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00002826-199417001-00010'" tppabs="https://doi.org/10.1097%2F00002826-199417001-00010" class="external text external">10.1097/00002826-199417001-00010</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7954487  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7954487'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7954487" class="external text external">7954487</a>.</cite></span></li><li id="cite_note-AURORIX-78"> <span id="mw-reference-text-cite_note-AURORIX-78" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-04017-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-04017-3'" tppabs="https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-04017-3" class="external text external">"NAME OF THE DRUG AURORIX"</a>. <i>TGA eBusiness Services</i>. Meda Valeant Pharma Australia Pty Limited. 7 January 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">16 October</span> 2013</span>.</cite></span></li><li id="cite_note-pmid2248085-79"> <span id="mw-reference-text-cite_note-pmid2248085-79" class="mw-reference-text"><cite id="CITEREFZimmerGieschkeFischbachGasic1990" class="citation journal cs1">Zimmer R, Gieschke R, Fischbach R, Gasic S (1990). "Interaction studies with moclobemide". <i>Acta Psychiatr Scand Suppl</i>. <b>360</b>: 84–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1990.tb05343.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1990.tb05343.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1990.tb05343.x" class="external text external">10.1111/j.1600-0447.1990.tb05343.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2248085  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2248085'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2248085" class="external text external">2248085</a>.</cite></span></li><li id="cite_note-pmid1546135-80"> <span id="mw-reference-text-cite_note-pmid1546135-80" class="mw-reference-text"><cite id="CITEREFAmreinGüntertDingemanseLorscheid1992" class="citation journal cs1">Amrein R, Güntert TW, Dingemanse J, Lorscheid T, Stabl M, Schmid-Burgk W (1992). "Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies". <i>Psychopharmacology</i>. 106 Suppl: S24–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02246229  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02246229'" tppabs="https://doi.org/10.1007%2Fbf02246229" class="external text external">10.1007/bf02246229</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1546135  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1546135'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1546135" class="external text external">1546135</a>.</cite></span></li><li id="cite_note-pmid8468439-81"> <span id="mw-reference-text-cite_note-pmid8468439-81" class="mw-reference-text"><cite id="CITEREFDingemanse_J1993" class="citation journal cs1">Dingemanse J (January 1993). "An update of recent moclobemide interaction data". <i>Int Clin Psychopharmacol</i>. <b>7</b> (3–4): 167–80. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199300730-00008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199300730-00008'" tppabs="https://doi.org/10.1097%2F00004850-199300730-00008" class="external text external">10.1097/00004850-199300730-00008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8468439  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8468439'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8468439" class="external text external">8468439</a>.</cite></span></li><li id="cite_note-pmid9669190-82"> <span id="mw-reference-text-cite_note-pmid9669190-82" class="mw-reference-text"><cite id="CITEREFDuncanSayalMcConnellTaylor1998" class="citation journal cs1">Duncan D, Sayal K, McConnell H, Taylor D (March 1998). "Antidepressant interactions with warfarin". <i>Int Clin Psychopharmacol</i>. <b>13</b> (2): 87–94. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199803000-00006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199803000-00006'" tppabs="https://doi.org/10.1097%2F00004850-199803000-00006" class="external text external">10.1097/00004850-199803000-00006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9669190  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9669190'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9669190" class="external text external">9669190</a>.</cite></span></li><li id="cite_note-pmid8713690-83"> <span id="mw-reference-text-cite_note-pmid8713690-83" class="mw-reference-text"><cite id="CITEREFLivingstonLivingston1996" class="citation journal cs1">Livingston MG, Livingston HM (April 1996). "Monoamine oxidase inhibitors. An update on drug interactions". <i>Drug Saf</i>. <b>14</b> (4): 219–27. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00002018-199614040-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00002018-199614040-00002'" tppabs="https://doi.org/10.2165%2F00002018-199614040-00002" class="external text external">10.2165/00002018-199614040-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8713690  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8713690'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8713690" class="external text external">8713690</a>.</cite></span></li><li id="cite_note-pmid9224903-84"> <span id="mw-reference-text-cite_note-pmid9224903-84" class="mw-reference-text"><cite id="CITEREFHiltonMaraditMöller1997" class="citation journal cs1">Hilton SE, Maradit H, Möller HJ (1997). "Serotonin syndrome and drug combinations: focus on MAOI and RIMA". <i>Eur Arch Psychiatry Clin Neurosci</i>. <b>247</b> (3): 113–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2FBF03033064  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2FBF03033064'" tppabs="https://doi.org/10.1007%2FBF03033064" class="external text external">10.1007/BF03033064</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9224903  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9224903'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9224903" class="external text external">9224903</a>.</cite></span></li><li id="cite_note-pmid8255982-85"> <span id="mw-reference-text-cite_note-pmid8255982-85" class="mw-reference-text"><cite id="CITEREFTiller_JW1993" class="citation journal cs1">Tiller JW (September 1993). "Clinical overview on moclobemide". <i>Prog. Neuropsychopharmacol. Biol. Psychiatry</i>. <b>17</b> (5): 703–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0278-5846%2893%2990054-V  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0278-5846%2893%2990054-V'" tppabs="https://doi.org/10.1016%2F0278-5846%2893%2990054-V" class="external text external">10.1016/0278-5846(93)90054-V</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8255982  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8255982'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8255982" class="external text external">8255982</a>.</cite></span></li><li id="cite_note-pmid16104086-86"> <span id="mw-reference-text-cite_note-pmid16104086-86" class="mw-reference-text"><cite id="CITEREFZivanovićTill1992" class="citation journal cs1">Zivanović O, Till E (1992). "[Serotonin syndrome--a case account]". <i>Med. Pregl</i>. <b>45</b> (3–4): 116–8. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16104086  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16104086'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16104086" class="external text external">16104086</a>.</cite></span></li><li id="cite_note-pmid8443525-87"> <span id="mw-reference-text-cite_note-pmid8443525-87" class="mw-reference-text"><cite id="CITEREFSpigsetMjörndalLövheim1993" class="citation journal cs1">Spigset O, Mjörndal T, Lövheim O (January 1993). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1676747  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1676747'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1676747" class="external text external">"Serotonin syndrome caused by a moclobemide-clomipramine interaction"</a>. <i>BMJ</i>. <b>306</b> (6872): 248. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.306.6872.248  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.306.6872.248'" tppabs="https://doi.org/10.1136%2Fbmj.306.6872.248" class="external text external">10.1136/bmj.306.6872.248</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1676747  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1676747'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1676747" class="external text external">1676747</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8443525  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8443525'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8443525" class="external text external">8443525</a>.</cite></span></li><li id="cite_note-pmid9631680-88"> <span id="mw-reference-text-cite_note-pmid9631680-88" class="mw-reference-text"><cite id="CITEREFRoxanasMachado1998" class="citation journal cs1">Roxanas MG, Machado JF (May 1998). "Serotonin syndrome in combined moclobemide and venlafaxine ingestion". <i>Med. J. Aust</i>. <b>168</b> (10): 523–4. doi:<a href="javascript:if(confirm('https://doi.org/10.5694%2Fj.1326-5377.1998.tb141428.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5694%2Fj.1326-5377.1998.tb141428.x'" tppabs="https://doi.org/10.5694%2Fj.1326-5377.1998.tb141428.x" class="external text external">10.5694/j.1326-5377.1998.tb141428.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9631680  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9631680'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9631680" class="external text external">9631680</a>.</cite></span></li><li id="cite_note-pmid9271778-89"> <span id="mw-reference-text-cite_note-pmid9271778-89" class="mw-reference-text"><cite id="CITEREFKönigWolfersdorfLöbleWössner1997" class="citation journal cs1">König F, Wolfersdorf M, Löble M, Wössner S, Hauger B (July 1997). "Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression". <i>Pharmacopsychiatry</i>. <b>30</b> (4): 125–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1055%2Fs-2007-979497  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1055%2Fs-2007-979497'" tppabs="https://doi.org/10.1055%2Fs-2007-979497" class="external text external">10.1055/s-2007-979497</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9271778  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9271778'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9271778" class="external text external">9271778</a>.</cite></span></li><li id="cite_note-pmid9399014-90"> <span id="mw-reference-text-cite_note-pmid9399014-90" class="mw-reference-text"><cite id="CITEREFRolan_P1997" class="citation journal cs1">Rolan P (October 1997). "Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90)". <i>Cephalalgia</i>. 17 Suppl 18 (18_suppl): 21–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0333102497017S1804  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0333102497017S1804'" tppabs="https://doi.org/10.1177%2F0333102497017S1804" class="external text external">10.1177/0333102497017S1804</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9399014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9399014'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9399014" class="external text external">9399014</a>.</cite></span></li><li id="cite_note-pmid9489930-91"> <span id="mw-reference-text-cite_note-pmid9489930-91" class="mw-reference-text"><cite id="CITEREFHärtterDingemanseBaierZiegler1998" class="citation journal cs1">Härtter S, Dingemanse J, Baier D, Ziegler G, Hiemke C (January 1998). "Inhibition of dextromethorphan metabolism by moclobemide". <i>Psychopharmacology</i>. <b>135</b> (1): 22–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs002130050481  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs002130050481'" tppabs="https://doi.org/10.1007%2Fs002130050481" class="external text external">10.1007/s002130050481</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9489930  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9489930'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9489930" class="external text external">9489930</a>.</cite></span></li><li id="cite_note-92"> <span id="mw-reference-text-cite_note-92" class="mw-reference-text"><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01171  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01171'" tppabs="https://www.drugbank.ca/drugs/DB01171" class="external free external">https://www.drugbank.ca/drugs/DB01171</a></span></li><li id="cite_note-Lavian-1993-93"> <span id="mw-reference-text-cite_note-Lavian-1993-93" class="mw-reference-text"><cite id="CITEREFLavianFinbergYoudim1993" class="citation journal cs1">Lavian, G.; Finberg, JP.; Youdim, MB. (1993). "The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine". <i>Clin Neuropharmacol</i>. 16 Suppl 2: S1–7. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8313392  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8313392'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8313392" class="external text external">8313392</a>.</cite></span></li><li id="cite_note-pmid3283290-94"> <span id="mw-reference-text-cite_note-pmid3283290-94" class="mw-reference-text"><cite id="CITEREFDa_PradaZürcherWüthrichHaefely1988" class="citation journal cs1">Da Prada M, Zürcher G, Wüthrich I, Haefely WE (1988). "On tyramine, food, beverages and the reversible MAO inhibitor moclobemide". <i>J. Neural Transm. Suppl</i>. <b>26</b>: 31–56. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3283290  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3283290'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3283290" class="external text external">3283290</a>.</cite></span></li><li id="cite_note-pmid2248084-95"> <span id="mw-reference-text-cite_note-pmid2248084-95" class="mw-reference-text"><cite id="CITEREFZimmer_R1990" class="citation journal cs1">Zimmer R (1990). "Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors". <i>Acta Psychiatr Scand Suppl</i>. <b>360</b>: 81–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.1990.tb05342.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.1990.tb05342.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.1990.tb05342.x" class="external text external">10.1111/j.1600-0447.1990.tb05342.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2248084  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2248084'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2248084" class="external text external">2248084</a>.</cite></span></li><li id="cite_note-pmid9673855-96"> <span id="mw-reference-text-cite_note-pmid9673855-96" class="mw-reference-text"><cite id="CITEREFHeinonenMyllylä1998" class="citation journal cs1">Heinonen EH, Myllylä V (July 1998). "Safety of selegiline (deprenyl) in the treatment of Parkinson's disease". <i>Drug Saf</i>. <b>19</b> (1): 11–22. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00002018-199819010-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00002018-199819010-00002'" tppabs="https://doi.org/10.2165%2F00002018-199819010-00002" class="external text external">10.2165/00002018-199819010-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9673855  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9673855'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9673855" class="external text external">9673855</a>.</cite></span></li><li id="cite_note-pmid8857072-97"> <span id="mw-reference-text-cite_note-pmid8857072-97" class="mw-reference-text"><cite id="CITEREFKornWagnerMoritzDingemanse1996" class="citation journal cs1">Korn A, Wagner B, Moritz E, Dingemanse J (1996). "Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline". <i>Eur. J. Clin. Pharmacol</i>. <b>49</b> (4): 273–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2FBF00226327  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2FBF00226327'" tppabs="https://doi.org/10.1007%2FBF00226327" class="external text external">10.1007/BF00226327</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8857072  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8857072'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8857072" class="external text external">8857072</a>.</cite></span></li><li id="cite_note-pmid8861736-98"> <span id="mw-reference-text-cite_note-pmid8861736-98" class="mw-reference-text"><cite id="CITEREFDingemanseHussainKorn1996" class="citation journal cs1">Dingemanse J, Hussain Y, Korn A (April 1996). "Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide". <i>Int J Clin Pharmacol Ther</i>. <b>34</b> (4): 172–7. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8861736  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8861736'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8861736" class="external text external">8861736</a>.</cite></span></li><li id="cite_note-pmid1546127-99"> <span id="mw-reference-text-cite_note-pmid1546127-99" class="mw-reference-text"><cite id="CITEREFHetzel_W1992" class="citation journal cs1">Hetzel W (1992). "Safety of moclobemide taken in overdose for attempted suicide". <i>Psychopharmacology</i>. 106 Suppl: S127–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02246256  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02246256'" tppabs="https://doi.org/10.1007%2Fbf02246256" class="external text external">10.1007/bf02246256</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1546127  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1546127'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1546127" class="external text external">1546127</a>.</cite></span></li><li id="cite_note-pmid8433071-100"> <span id="mw-reference-text-cite_note-pmid8433071-100" class="mw-reference-text"><cite id="CITEREFMyrenforsErikssonSandstedSjöberg1993" class="citation journal cs1">Myrenfors PG, Eriksson T, Sandsted CS, Sjöberg G (February 1993). "Moclobemide overdose". <i>J. Intern. Med</i>. <b>233</b> (2): 113–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2796.1993.tb00662.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2796.1993.tb00662.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2796.1993.tb00662.x" class="external text external">10.1111/j.1365-2796.1993.tb00662.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8433071  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8433071'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8433071" class="external text external">8433071</a>.</cite></span></li><li id="cite_note-pmid7901695-101"> <span id="mw-reference-text-cite_note-pmid7901695-101" class="mw-reference-text"><cite id="CITEREFNeuvonenPohjola-SintonenTackeVuori1993" class="citation journal cs1">Neuvonen PJ, Pohjola-Sintonen S, Tacke U, Vuori E (December 1993). "Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses". <i>Lancet</i>. <b>342</b> (8884): 1419. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0140-6736%2893%2992774-N  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0140-6736%2893%2992774-N'" tppabs="https://doi.org/10.1016%2F0140-6736%2893%2992774-N" class="external text external">10.1016/0140-6736(93)92774-N</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7901695  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7901695'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7901695" class="external text external">7901695</a>.</cite></span></li><li id="cite_note-pmid7819894-102"> <span id="mw-reference-text-cite_note-pmid7819894-102" class="mw-reference-text"><cite id="CITEREFIsacssonRedforsWassermanBergman1994" class="citation journal cs1">Isacsson G, Redfors I, Wasserman D, Bergman U (December 1994). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2541721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2541721'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2541721" class="external text external">"Choice of antidepressants: questionnaire survey of psychiatrists and general practitioners in two areas of Sweden"</a>. <i>BMJ</i>. <b>309</b> (6968): 1546–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.309.6968.1546  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.309.6968.1546'" tppabs="https://doi.org/10.1136%2Fbmj.309.6968.1546" class="external text external">10.1136/bmj.309.6968.1546</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2541721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2541721'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2541721" class="external text external">2541721</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7819894  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7819894'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7819894" class="external text external">7819894</a>.</cite></span></li><li id="cite_note-Curtin-2002-103"> <span id="mw-reference-text-cite_note-Curtin-2002-103" class="mw-reference-text"><cite id="CITEREFCurtinBerneyKaufmann2002" class="citation journal cs1">Curtin, F.; Berney, P.; Kaufmann, C. (Sep 2002). "Moclobemide discontinuation syndrome predominantly presenting with influenza-like symptoms". <i>J Psychopharmacol</i>. <b>16</b> (3): 271–2. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F026988110201600314  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F026988110201600314'" tppabs="https://doi.org/10.1177%2F026988110201600314" class="external text external">10.1177/026988110201600314</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12236637  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12236637'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12236637" class="external text external">12236637</a>.</cite></span></li><li id="cite_note-pmid8889907-104"> <span id="mw-reference-text-cite_note-pmid8889907-104" class="mw-reference-text"><cite id="CITEREFCouplandBellPotokar1996" class="citation journal cs1">Coupland NJ, Bell CJ, Potokar JP (October 1996). "Serotonin reuptake inhibitor withdrawal". <i>J Clin Psychopharmacol</i>. <b>16</b> (5): 356–62. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004714-199610000-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004714-199610000-00003'" tppabs="https://doi.org/10.1097%2F00004714-199610000-00003" class="external text external">10.1097/00004714-199610000-00003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8889907  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8889907'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8889907" class="external text external">8889907</a>.</cite></span></li><li id="cite_note-pmid9112832-105"> <span id="mw-reference-text-cite_note-pmid9112832-105" class="mw-reference-text"><cite id="CITEREFGhanbarpourHadizadehPiriRashidi-Ranjbar1997" class="citation journal cs1">Ghanbarpour A, Hadizadeh F, Piri F, Rashidi-Ranjbar P (April 1997). "Synthesis, conformational analysis and antidepressant activity of moclobemide new analogues". <i>Pharm Acta Helv</i>. <b>72</b> (2): 119–22. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0031-6865%2897%2900004-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0031-6865%2897%2900004-6'" tppabs="https://doi.org/10.1016%2FS0031-6865%2897%2900004-6" class="external text external">10.1016/S0031-6865(97)00004-6</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9112832  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9112832'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9112832" class="external text external">9112832</a>.</cite></span></li><li id="cite_note-Nair-106"> <span id="mw-reference-text-cite_note-Nair-106" class="mw-reference-text"><cite id="CITEREFNairS._K._AhmedN._M._Kin1993" class="citation journal cs1">Nair, N. P.; S. K. Ahmed; N. M. Kin (November 1993). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542" class="external text external">"Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide"</a>. <i>Journal of Psychiatry &amp; Neuroscience</i>. <b>18</b> (5): 214–225. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188542" class="external text external">1188542</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7905288  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7905288'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7905288" class="external text external">7905288</a>.</cite></span></li><li id="cite_note-pmid1546143-107"> <span id="mw-reference-text-cite_note-pmid1546143-107" class="mw-reference-text"><cite id="CITEREFHaefelyBurkardCesura1992" class="citation journal cs1">Haefely W, Burkard WP, Cesura AM,  et al. (1992). "Biochemistry and pharmacology of moclobemide, a prototype RIMA". <i>Psychopharmacology</i>. 106 Suppl: S6–14. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02246225  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02246225'" tppabs="https://doi.org/10.1007%2Fbf02246225" class="external text external">10.1007/bf02246225</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1546143  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1546143'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1546143" class="external text external">1546143</a>.</cite></span></li><li id="cite_note-pmid8923574-108"> <span id="mw-reference-text-cite_note-pmid8923574-108" class="mw-reference-text"><cite id="CITEREFRadatBerlinSpreux-VaroquauxElatki1996" class="citation journal cs1">Radat F, Berlin I, Spreux-Varoquaux O, Elatki S, Ferreri M, Puech AJ (October 1996). "Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study". <i>Psychopharmacology</i>. <b>127</b> (4): 370–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02806017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02806017'" tppabs="https://doi.org/10.1007%2Fbf02806017" class="external text external">10.1007/bf02806017</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8923574  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8923574'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8923574" class="external text external">8923574</a>.</cite></span></li><li id="cite_note-pmid7519866-109"> <span id="mw-reference-text-cite_note-pmid7519866-109" class="mw-reference-text"><cite id="CITEREFHolfordGuentertDingemanseBanken1994" class="citation journal cs1">Holford NH, Guentert TW, Dingemanse J, Banken L (May 1994). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364898  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364898'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364898" class="external text external">"Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor"</a>. <i>Br J Clin Pharmacol</i>. <b>37</b> (5): 433–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2125.1994.tb05710.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2125.1994.tb05710.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2125.1994.tb05710.x" class="external text external">10.1111/j.1365-2125.1994.tb05710.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364898  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364898'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364898" class="external text external">1364898</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7519866  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7519866'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7519866" class="external text external">7519866</a>.</cite></span></li><li id="cite_note-pmid1546145-110"> <span id="mw-reference-text-cite_note-pmid1546145-110" class="mw-reference-text"><cite id="CITEREFDingemanseBerlinPayanThiede1992" class="citation journal cs1">Dingemanse J, Berlin I, Payan C, Thiede HM, Puech AJ (1992). "Comparative investigation of the effect of moclobemide and toloxatone on monoamine oxidase activity and psychometric performance in healthy subjects". <i>Psychopharmacology</i>. 106 Suppl: S68–70. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02246239  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02246239'" tppabs="https://doi.org/10.1007%2Fbf02246239" class="external text external">10.1007/bf02246239</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1546145  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1546145'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1546145" class="external text external">1546145</a>.</cite></span></li><li id="cite_note-Haefely-1993-111"> <span id="mw-reference-text-cite_note-Haefely-1993-111" class="mw-reference-text"><cite id="CITEREFHaefelyBurkardCesuraColzi1993" class="citation journal cs1">Haefely, W.; Burkard, WP.; Cesura, A.; Colzi, A.; Kettler, R.; Lorez, HP.; Martin, JR.; Moreau, JL.;  et al. (1993). "Pharmacology of moclobemide". <i>Clin Neuropharmacol</i>. 16 Suppl 2: S8–18. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8313402  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8313402'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8313402" class="external text external">8313402</a>.</cite></span></li><li id="cite_note-pmid10760560-112"> <span id="mw-reference-text-cite_note-pmid10760560-112" class="mw-reference-text"><cite id="CITEREFLinSongKenis2000" class="citation journal cs1">Lin A, Song C, Kenis G,  et al. (April 2000). "The in vitro immunosuppressive effects of moclobemide in healthy volunteers". <i>J Affect Disord</i>. <b>58</b> (1): 69–74. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0165-0327%2899%2900076-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0165-0327%2899%2900076-2'" tppabs="https://doi.org/10.1016%2FS0165-0327%2899%2900076-2" class="external text external">10.1016/S0165-0327(99)00076-2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10760560  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10760560'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10760560" class="external text external">10760560</a>.</cite></span></li><li id="cite_note-pmid9694007-113"> <span id="mw-reference-text-cite_note-pmid9694007-113" class="mw-reference-text"><cite id="CITEREFMoriZanardiPopoli1998" class="citation journal cs1">Mori S, Zanardi R, Popoli M,  et al. (1998). "cAMP-dependent phosphorylation system after short and long-term administration of moclobemide". <i>J Psychiatr Res</i>. <b>32</b> (2): 111–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0022-3956%2898%2900003-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0022-3956%2898%2900003-X'" tppabs="https://doi.org/10.1016%2FS0022-3956%2898%2900003-X" class="external text external">10.1016/S0022-3956(98)00003-X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9694007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9694007'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9694007" class="external text external">9694007</a>.</cite></span></li><li id="cite_note-pmid2677242-114"> <span id="mw-reference-text-cite_note-pmid2677242-114" class="mw-reference-text"><cite id="CITEREFDa_PradaKettlerKellerBurkard1989" class="citation journal cs1">Da Prada M, Kettler R, Keller HH, Burkard WP, Haefely WE (1989). "Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors". <i>J. Neural Transm. Suppl</i>. <b>28</b>: 5–20. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2677242  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2677242'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2677242" class="external text external">2677242</a>.</cite></span></li><li id="cite_note-Plasma_sex_hormones_and_urinary_biogenic_amine_metabolites_during_treatment_of_male_depressed_patients_with_the_monoamine_oxidase_inhibitor_moclobemide-115"> <span id="mw-reference-text-cite_note-Plasma_sex_hormones_and_urinary_biogenic_amine_metabolites_during_treatment_of_male_depressed_patients_with_the_monoamine_oxidase_inhibitor_moclobemide-115" class="mw-reference-text"><cite id="CITEREFMarkianosAlevizosStefanis1991" class="citation journal cs1">Markianos M, Alevizos V, Stefanis C (1991). "Plasma sex hormones and urinary biogenic amine metabolites during treatment of male depressed patients with the monoamine oxidase inhibitor moclobemide". <i>Neuro Endocrinology Letters</i>. <b>13</b> (1): 49–55. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0172-780X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0172-780X'" tppabs="https://www.worldcat.org/issn/0172-780X" class="external text external">0172-780X</a>.</cite></span></li><li id="cite_note-pmid8375130-116"> <span id="mw-reference-text-cite_note-pmid8375130-116" class="mw-reference-text"><cite id="CITEREFCoquozPorchetDayer1993" class="citation journal cs1">Coquoz D, Porchet HC, Dayer P (September 1993). "Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers". <i>Clin. Pharmacol. Ther</i>. <b>54</b> (3): 339–44. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fclpt.1993.156  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fclpt.1993.156'" tppabs="https://doi.org/10.1038%2Fclpt.1993.156" class="external text external">10.1038/clpt.1993.156</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8375130  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8375130'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8375130" class="external text external">8375130</a>.</cite></span></li><li id="cite_note-pmid9663810-117"> <span id="mw-reference-text-cite_note-pmid9663810-117" class="mw-reference-text"><cite id="CITEREFBitsiosLangleyTavernor1998" class="citation journal cs1">Bitsios P, Langley RW, Tavernor S,  et al. (June 1998). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1873648  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1873648'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1873648" class="external text external">"Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man"</a>. <i>Br J Clin Pharmacol</i>. <b>45</b> (6): 551–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1365-2125.1998.00729.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1365-2125.1998.00729.x'" tppabs="https://doi.org/10.1046%2Fj.1365-2125.1998.00729.x" class="external text external">10.1046/j.1365-2125.1998.00729.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1873648  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1873648'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1873648" class="external text external">1873648</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9663810  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9663810'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9663810" class="external text external">9663810</a>.</cite></span></li><li id="cite_note-pmid8259692-118"> <span id="mw-reference-text-cite_note-pmid8259692-118" class="mw-reference-text"><cite id="CITEREFVallèsCoassoloDe_SousaAubert1993" class="citation journal cs1">Vallès B, Coassolo P, De Sousa G, Aubert C, Rahmani R (October 1993). "In vitro hepatic biotransformation of moclobemide (Ro 11-1163) in man and rat". <i>Xenobiotica</i>. <b>23</b> (10): 1101–11. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F00498259309059425  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F00498259309059425'" tppabs="https://doi.org/10.3109%2F00498259309059425" class="external text external">10.3109/00498259309059425</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8259692  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8259692'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8259692" class="external text external">8259692</a>.</cite></span></li><li id="cite_note-pmid8582117-119"> <span id="mw-reference-text-cite_note-pmid8582117-119" class="mw-reference-text"><cite id="CITEREFMayersohnGuentert1995" class="citation journal cs1">Mayersohn M, Guentert TW (November 1995). "Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide". <i>Clin Pharmacokinet</i>. <b>29</b> (5): 292–332. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-199529050-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-199529050-00002'" tppabs="https://doi.org/10.2165%2F00003088-199529050-00002" class="external text external">10.2165/00003088-199529050-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8582117  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8582117'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8582117" class="external text external">8582117</a>.</cite></span></li><li id="cite_note-Lei-120"> <span id="mw-reference-text-cite_note-Lei-120" class="mw-reference-text"><cite id="CITEREFLeikinPaloucek2007" class="citation book cs1">Leikin, Jerrold B.; Paloucek, Frank P. (2007). <a href="javascript:if(confirm('https://books.google.com/books?id=0Bw2UJTC_uMC&pg=PA475&lpg=PA475&dq=moclobemide+half-life+elimination&source=bl&ots=W57mEtjpVx&sig=TZFCHZ9JT8mRGHPvNVrb-LiHIiQ&hl=en&ei=fRkdSpbcFY7UjAfdjviGDQ&sa=X&oi=book_result&ct=result&resnum=2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0Bw2UJTC_uMC&pg=PA475&lpg=PA475&dq=moclobemide+half-life+elimination&source=bl&ots=W57mEtjpVx&sig=TZFCHZ9JT8mRGHPvNVrb-LiHIiQ&hl=en&ei=fRkdSpbcFY7UjAfdjviGDQ&sa=X&oi=book_result&ct=result&resnum=2#PPA475,M1'" tppabs="https://books.google.com/books?id=0Bw2UJTC_uMC&pg=PA475&lpg=PA475&dq=moclobemide+half-life+elimination&source=bl&ots=W57mEtjpVx&sig=TZFCHZ9JT8mRGHPvNVrb-LiHIiQ&hl=en&ei=fRkdSpbcFY7UjAfdjviGDQ&sa=X&oi=book_result&ct=result&resnum=2#PPA475,M1" class="external text external">"Moclobemide"</a>. <a href="javascript:if(confirm('https://books.google.com/?id=0Bw2UJTC_uMC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=0Bw2UJTC_uMC'" tppabs="https://books.google.com/?id=0Bw2UJTC_uMC" class="external text external"><i>Poisoning and toxicology handbook</i></a> (4th ed.). Informa Health Care. p.<span>&nbsp;</span>1331. ISBN<span>&nbsp;</span><bdi>978-1-4200-4479-9</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">26 May</span> 2009</span>.</cite></span></li><li id="cite_note-Gram-121"> <span id="mw-reference-text-cite_note-Gram-121" class="mw-reference-text"><cite id="CITEREFGram_L._F.Guentert_T._W.Grange_S.1995" class="citation journal cs1">Gram L. F.; Guentert T. W.; Grange S.;  et al. (June 1995). "Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study". <i>Clinical Pharmacology &amp; Therapeutics</i>. <b>57</b> (6): 670–677. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0009-9236%2895%2990230-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0009-9236%2895%2990230-9'" tppabs="https://doi.org/10.1016%2F0009-9236%2895%2990230-9" class="external text external">10.1016/0009-9236(95)90230-9</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0009-9236  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0009-9236'" tppabs="https://www.worldcat.org/issn/0009-9236" class="external text external">0009-9236</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7781267  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7781267'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7781267" class="external text external">7781267</a>.</cite></span></li><li id="cite_note-Din-122"> <span id="mw-reference-text-cite_note-Din-122" class="mw-reference-text"><cite id="CITEREFHärtter_S.Dingemanse_J.Baier_D.1996" class="citation journal cs1">Härtter S.; Dingemanse J.; Baier D.;  et al. (August 1996). "The role of cytochrome P450 2D6 in the metabolism of moclobemide". <i>European Neuropsychopharmacology</i>. <b>6</b> (3): 225–230. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0924-977X%2896%2900023-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0924-977X%2896%2900023-5'" tppabs="https://doi.org/10.1016%2F0924-977X%2896%2900023-5" class="external text external">10.1016/0924-977X(96)00023-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8880082  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8880082'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8880082" class="external text external">8880082</a>.</cite></span></li><li id="cite_note-pmid8329293-123"> <span id="mw-reference-text-cite_note-pmid8329293-123" class="mw-reference-text"><cite id="CITEREFGramBrøsen1993" class="citation journal cs1">Gram LF, Brøsen K (June 1993). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1381610  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1381610'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1381610" class="external text external">"Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group"</a>. <i>Br J Clin Pharmacol</i>. <b>35</b> (6): 649–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2125.1993.tb04196.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2125.1993.tb04196.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2125.1993.tb04196.x" class="external text external">10.1111/j.1365-2125.1993.tb04196.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1381610  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1381610'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1381610" class="external text external">1381610</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8329293  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8329293'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8329293" class="external text external">8329293</a>.</cite></span></li><li id="cite_note-pmid2685852-124"> <span id="mw-reference-text-cite_note-pmid2685852-124" class="mw-reference-text"><cite id="CITEREFSchoerlinGuentert1989" class="citation journal cs1">Schoerlin MP, Guentert TW (August 1989). "[Pharmacokinetics and metabolism of reversible MAO-A inhibitors in the human]". <i>Psychiatr Prax</i> (in German). 16 Suppl 1: 11–7. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2685852  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2685852'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2685852" class="external text external">2685852</a>.</cite></span></li><li id="cite_note-pmid6538424-125"> <span id="mw-reference-text-cite_note-pmid6538424-125" class="mw-reference-text"><cite id="CITEREFRaaflaubHaefelfingerTrautmann1984" class="citation journal cs1">Raaflaub J, Haefelfinger P, Trautmann KH (1984). "Single-dose pharmacokinetics of the MAO-inhibitor moclobemide in man". <i>Arzneimittelforschung</i>. <b>34</b> (1): 80–2. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6538424  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6538424'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6538424" class="external text external">6538424</a>.</cite></span></li><li id="cite_note-pmid9259175-126"> <span id="mw-reference-text-cite_note-pmid9259175-126" class="mw-reference-text"><cite id="CITEREFGoldberg_RJ1997" class="citation journal cs1">Goldberg RJ (August 1997). "Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide". <i>Drugs Aging</i>. <b>11</b> (2): 119–31. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00002512-199711020-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00002512-199711020-00004'" tppabs="https://doi.org/10.2165%2F00002512-199711020-00004" class="external text external">10.2165/00002512-199711020-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9259175  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9259175'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9259175" class="external text external">9259175</a>.</cite></span></li><li id="cite_note-pmid1705137-127"> <span id="mw-reference-text-cite_note-pmid1705137-127" class="mw-reference-text"><cite id="CITEREFBerlinZimmerThiede1990" class="citation journal cs1">Berlin I, Zimmer R, Thiede HM,  et al. (December 1990). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1368300  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1368300'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1368300" class="external text external">"Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects"</a>. <i>Br J Clin Pharmacol</i>. <b>30</b> (6): 805–16. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2125.1990.tb05445.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2125.1990.tb05445.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2125.1990.tb05445.x" class="external text external">10.1111/j.1365-2125.1990.tb05445.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1368300  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1368300'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1368300" class="external text external">1368300</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1705137  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1705137'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1705137" class="external text external">1705137</a>.</cite></span></li><li id="cite_note-pmid1609042-128"> <span id="mw-reference-text-cite_note-pmid1609042-128" class="mw-reference-text"><cite id="CITEREFRudorfer_MV1992" class="citation journal cs1">Rudorfer MV (1992). "Monoamine oxidase inhibitors: reversible and irreversible". <i>Psychopharmacol Bull</i>. <b>28</b> (1): 45–57. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1609042  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1609042'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1609042" class="external text external">1609042</a>.</cite></span></li><li id="cite_note-pmid7593735-129"> <span id="mw-reference-text-cite_note-pmid7593735-129" class="mw-reference-text"><cite id="CITEREFHiltonJaberRuch1995" class="citation journal cs1">Hilton S, Jaber B, Ruch R (August 1995). "Moclobemide safety: monitoring a newly developed product in the 1990s". <i>J Clin Psychopharmacol</i>. <b>15</b> (4 Suppl 2): 76S–83S. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004714-199508001-00013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004714-199508001-00013'" tppabs="https://doi.org/10.1097%2F00004714-199508001-00013" class="external text external">10.1097/00004714-199508001-00013</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7593735  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7593735'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7593735" class="external text external">7593735</a>.</cite></span></li><li id="cite_note-pmid9005342-130"> <span id="mw-reference-text-cite_note-pmid9005342-130" class="mw-reference-text"><cite id="CITEREFVolzGleiterMöller1996" class="citation journal cs1">Volz HP, Gleiter CH, Möller HJ (May 1996). "[Monoamine oxidase inhibitors in psychiatry. Status of current knowledge]". <i>Nervenarzt</i> (in German). <b>67</b> (5): 339–47. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9005342  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9005342'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9005342" class="external text external">9005342</a>.</cite></span></li><li id="cite_note-pmid7980156-131"> <span id="mw-reference-text-cite_note-pmid7980156-131" class="mw-reference-text"><cite class="citation journal cs1">Mitchell PB, Mitchell MS (August 1994). "The management of depression. The place of the new antidepressants. Part 1. General overview". <i>Aust Fam Physician</i>. <b>23</b> (8): 1555–9, 1562. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7980156  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7980156'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7980156" class="external text external">7980156</a>.</cite></span></li><li id="cite_note-pmid8923103-132"> <span id="mw-reference-text-cite_note-pmid8923103-132" class="mw-reference-text"><cite id="CITEREFAngstAmreinStabl1996" class="citation journal cs1">Angst J, Amrein R, Stabl M (June 1996). "Moclobemide: a paradigm of research in clinical psychopharmacology". <i>Int Clin Psychopharmacol</i>. 11 Suppl 3: 3–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004850-199606003-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004850-199606003-00002'" tppabs="https://doi.org/10.1097%2F00004850-199606003-00002" class="external text external">10.1097/00004850-199606003-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8923103  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8923103'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8923103" class="external text external">8923103</a>.</cite></span></li><li id="cite_note-pmid9469236-133"> <span id="mw-reference-text-cite_note-pmid9469236-133" class="mw-reference-text"><cite class="citation journal cs1">Amrein R, Stabl M, Henauer S, Affolter E, Jonkanski I (December 1997). "Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview". <i>Can J Psychiatry</i>. <b>42</b> (10): 1043–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F070674379704201005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F070674379704201005'" tppabs="https://doi.org/10.1177%2F070674379704201005" class="external text external">10.1177/070674379704201005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9469236  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9469236'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9469236" class="external text external">9469236</a>.</cite></span></li><li id="cite_note-pmid8253702-134"> <span id="mw-reference-text-cite_note-pmid8253702-134" class="mw-reference-text"><cite id="CITEREFBech_P1993" class="citation journal cs1">Bech P (August 1993). "Acute therapy of depression". <i>J Clin Psychiatry</i>. 54 Suppl: 18–27, discussion 28. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8253702  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8253702'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8253702" class="external text external">8253702</a>.</cite></span></li><li id="cite_note-pmid9696909-135"> <span id="mw-reference-text-cite_note-pmid9696909-135" class="mw-reference-text"><cite id="CITEREFChebiliAbaoubMezouaneLe_Goff1998" class="citation journal cs1">Chebili S, Abaoub A, Mezouane B, Le Goff JF (1998). "[Antidepressants and sexual stimulation: the correlation]". <i>Encephale</i> (in French). <b>24</b> (3): 180–4. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9696909  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9696909'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9696909" class="external text external">9696909</a>.</cite></span></li><li id="cite_note-136"> <span id="mw-reference-text-cite_note-136" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.medapharma.com.br/produtos/produto/aurorixRmoclobemida/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medapharma.com.br/produtos/produto/aurorixRmoclobemida/'" tppabs="http://www.medapharma.com.br/produtos/produto/aurorixRmoclobemida/" class="external text external">"Aurorix®(moclobemida) - Meda"</a>. <i>www.medapharma.com.br</i> (in Portuguese)<span class="reference-accessdate">. Retrieved <span class="nowrap">2018-09-17</span></span>.</cite></span></li><li id="cite_note-drugs.comINTMoclobemide-137"> <span id="mw-reference-text-cite_note-drugs.comINTMoclobemide-137" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/Moclobemide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/Moclobemide.html'" tppabs="https://www.drugs.com/international/Moclobemide.html" class="external text external">"Moclobemide International Brands"</a>. Drugs.com<span class="reference-accessdate">. Retrieved <span class="nowrap">3 June</span> 2017</span>.</cite></span></li></ol></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<ul><li>Scientific Information on Aurorix (German)</li>
<li><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=189524  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=189524'" tppabs="https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=189524" class="external text external">PubChem Substance Summary: Moclobemide</a> National Center for Biotechnology Information.</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antidepressants_(N06A)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antidepressants_(N06A)" style="font-size:114%;margin:0 4em">Antidepressants (N06A)</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Specific_reuptake_inhibitors_and/or_receptor_modulators" style="font-size:114%;margin:0 4em">Specific reuptake inhibitors and/or receptor modulators</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>SSRIs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Citalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Citalopram" title="Citalopram">Citalopram</a></li>
<li><a href="Escitalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Escitalopram" title="Escitalopram">Escitalopram</a></li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a><sup>#</sup></li>
<li><a href="Fluvoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvoxamine" title="Fluvoxamine">Fluvoxamine</a></li>
<li>Indalpine<sup>‡</sup></li>
<li><a href="Paroxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paroxetine" title="Paroxetine">Paroxetine</a></li>
<li><a href="Sertraline.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertraline" title="Sertraline">Sertraline</a></li>
<li><a href="Zimelidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zimelidine" title="Zimelidine">Zimelidine</a><sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>SNRIs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Desvenlafaxine</li>
<li><a href="Duloxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Duloxetine" title="Duloxetine">Duloxetine</a></li>
<li>Levomilnacipran</li>
<li><a href="Milnacipran.htm" tppabs="https://ptable.com/wiki/compounds/A/Milnacipran" title="Milnacipran">Milnacipran</a></li>
<li>Tofenacin</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>NRIs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atomoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atomoxetine" title="Atomoxetine">Atomoxetine</a></li>
<li><a href="Reboxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reboxetine" title="Reboxetine">Reboxetine</a></li>
<li>Viloxazine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>NDRIs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a><sup>‡</sup></li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li><a href="Nomifensine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nomifensine" title="Nomifensine">Nomifensine</a><sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>NaSSAs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li><a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">Mirtazapine</a></li>
<li>Setiptiline</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>SARIs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Etoperidone</li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li><a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">Trazodone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>SMS</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Vilazodone</li>
<li>Vortioxetine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Agomelatine</li>
<li><a href="Amisulpride.htm" tppabs="https://ptable.com/wiki/compounds/A/Amisulpride" title="Amisulpride">Amisulpride</a></li>
<li>Esketamine<sup>†</sup></li>
<li><a href="Alpha-Ethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Ethyltryptamine" title="Alpha-Ethyltryptamine">Etryptamine</a><sup>‡</sup></li>
<li>Indeloxazine</li>
<li><a href="Flupentixol.htm" tppabs="https://ptable.com/wiki/compounds/A/Flupentixol" title="Flupentixol">flupentixol</a></li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a><sup>†</sup></li>
<li>Medifoxamine<sup>‡</sup></li>
<li><a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">Metryptamine</a><sup>‡</sup></li>
<li>Oxaflozane<sup>‡</sup></li>
<li>Pivagabine<sup>‡</sup></li>
<li>Tandospirone</li>
<li>Teniloxazine</li>
<li>Tianeptine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Tricyclic_and_tetracyclic_antidepressants" style="font-size:114%;margin:0 4em">Tricyclic and tetracyclic antidepressants</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>TCAs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a><sup>‡</sup></li>
<li><a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">Amitriptyline</a><sup>#</sup></li>
<li>Amitriptylinoxide</li>
<li>Butriptyline<sup>‡</sup></li>
<li><a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">Clomipramine</a><sup>#</sup></li>
<li>Demexiptiline<sup>‡</sup></li>
<li>Desipramine</li>
<li>Dibenzepin</li>
<li>Dimetacrine<sup>‡</sup></li>
<li>Dosulepin</li>
<li><a href="Doxepin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxepin" title="Doxepin">Doxepin</a></li>
<li><a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">Imipramine</a></li>
<li>Imipraminoxide<sup>‡</sup></li>
<li>Iprindole<sup>‡</sup></li>
<li>Lofepramine</li>
<li>Melitracen</li>
<li>Metapramine<sup>‡</sup></li>
<li>Nitroxazepine</li>
<li><a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">Nortriptyline</a></li>
<li>Noxiptiline</li>
<li>Opipramol</li>
<li>Pipofezine</li>
<li>Propizepine<sup>‡</sup></li>
<li><a href="Protriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Protriptyline" title="Protriptyline">Protriptyline</a></li>
<li>Quinupramine<sup>‡</sup></li>
<li>Tianeptine</li>
<li><a href="Trimipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimipramine" title="Trimipramine">Trimipramine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>TeCAs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li><a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">Maprotiline</a></li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li><a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">Mirtazapine</a></li>
<li>Setiptiline</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Tiazesim</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Monoamine_oxidase_inhibitors" style="font-size:114%;margin:0 4em">Monoamine oxidase inhibitors</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Non-selective</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Irreversible:</i> Benmoxin<sup>‡</sup></li>
<li>Iproclozide<sup>‡</sup></li>
<li><a href="Iproniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Iproniazid" title="Iproniazid">Iproniazid</a><sup>‡</sup></li>
<li><a href="Isocarboxazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isocarboxazid" title="Isocarboxazid">Isocarboxazid</a></li>
<li><a href="Isoniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoniazid" title="Isoniazid">Isoniazid</a><sup>#</sup></li>
<li><a href="Linezolid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linezolid" title="Linezolid">Linezolid</a><sup>#</sup></li>
<li>Mebanazine<sup>‡</sup></li>
<li><a href="Nialamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nialamide" title="Nialamide">Nialamide</a><sup>‡</sup></li>
<li>Octamoxin<sup>‡</sup></li>
<li><a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">Phenelzine</a></li>
<li>Pheniprazine<sup>‡</sup></li>
<li>Phenoxypropazine<sup>‡</sup></li>
<li>Pivhydrazine<sup>‡</sup></li>
<li>Safrazine<sup>‡</sup></li>
<li>Tedizolid</li>
<li><a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li></ul>

<ul><li><i>Reversible:</i> Caroxazone<sup>‡</sup></li></ul>

<ul><li><i>Mixed:</i> Bifemelane</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>MAO<sub>A</sub></abbr>-selective</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Reversible:</i> Eprobemide</li>
<li>Metralindole</li>
<li><a href="Minaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Minaprine" title="Minaprine">Minaprine</a><sup>‡</sup></li>
<li><a href="Moclobemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Moclobemide" title="Moclobemide">Moclobemide</a></li>
<li>Pirlindole</li>
<li>Tetrindole</li>
<li>Toloxatone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><abbr>MAO<sub>B</sub></abbr>-selective</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Irreversible:</i> <a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Adjunctive_therapies" style="font-size:114%;margin:0 4em">Adjunctive therapies</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Atypical antipsychotics (<a href="Aripiprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Aripiprazole" title="Aripiprazole">aripiprazole</a>, brexpiprazole, lurasidone, <a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">quetiapine</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>)</li>
<li><a href="Buspirone.htm" tppabs="https://ptable.com/wiki/compounds/A/Buspirone" title="Buspirone">Buspirone</a></li>
<li>Lithium (<a href="Lithium_carbonate.htm" tppabs="https://ptable.com/wiki/compounds/A/Lithium_carbonate" title="Lithium carbonate">lithium carbonate</a>, lithium citrate)</li>
<li><a href="Thyroid_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Thyroid_hormone" title="Thyroid hormone" class="mw-redirect">Thyroid hormones</a> (<a href="Triiodothyronine.htm" tppabs="https://ptable.com/wiki/compounds/A/Triiodothyronine" title="Triiodothyronine">triiodothyronine</a> (T<sub>3</sub>), <a href="Levothyroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levothyroxine" title="Levothyroxine">levothyroxine</a> (T<sub>4</sub>))</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Miscellaneous" style="font-size:114%;margin:0 4em">Miscellaneous</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="S-Adenosyl_methionine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ademetionine" title="Ademetionine" class="mw-redirect">Ademetionine (<abbr>SAMe</abbr>)</a></li>
<li><i>Hypericum perforatum</i> (St. John's Wort)</li>
<li><a href="5-Hydroxytryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxitriptan" title="Oxitriptan" class="mw-redirect">Oxitriptan (<abbr>5-HTP</abbr>)</a></li>
<li><a href="Rubidium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Rubidium_chloride" title="Rubidium chloride">Rubidium chloride (RbCl)</a></li>
<li><a href="Tryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptophan" title="Tryptophan">Tryptophan</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Monoamine_metabolism_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Monoamine_metabolism_modulators" style="font-size:114%;margin:0 4em">Monoamine metabolism modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Non-specific</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>AAAD</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a>→<a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li><a href="5-Hydroxytryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/5-HTP" title="5-HTP" class="mw-redirect">5-HTP</a>→<a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a></li>
<li><small>L</small>-Histidine→<a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine">Phenylalanine</a>→<a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><small>L</small>-Tyrosine→<a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">Tyramine</a></li>
<li><a href="Tryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptophan" title="Tryptophan">Tryptophan</a>→<a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">Tryptamine</a></li></ul>

<ul><li><b>Inhibitors:</b> Benserazide</li>
<li><a href="Carbidopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbidopa" title="Carbidopa">Carbidopa</a></li>
<li>DFMD</li>
<li><a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">Genistein</a></li>
<li><a href="Methyldopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyldopa" title="Methyldopa">Methyldopa</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>MAO</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products (with <abbr>ALDH</abbr>/<abbr>ALR</abbr>):</b> <a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine (adrenaline)</a>→DHMA</li>
<li>Metanephrine→MHPG/<a href="Vanillylmandelic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanillylmandelic_acid" title="Vanillylmandelic acid">VMA</a></li>
<li>Norepinephrine (noradrenaline)→DHMA</li>
<li>Normetanephrine→MHPG/<a href="Vanillylmandelic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanillylmandelic_acid" title="Vanillylmandelic acid">VMA</a></li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a>→<a href="3,4-Dihydroxyphenylacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Dihydroxyphenylacetic_acid" title="3,4-Dihydroxyphenylacetic acid">DOPAC</a></li>
<li><a href="3-Methoxytyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a>→<a href="Homovanillic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Homovanillic_acid" title="Homovanillic acid">HVA</a></li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a>→<a href="5-Hydroxyindoleacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Hydroxyindoleacetic_acid" title="5-Hydroxyindoleacetic acid">5-HIAA</a></li></ul>

<ul><li><b>Inhibitors:</b> <i>Non-selective:</i> Benmoxin</li>
<li>Caroxazone</li>
<li>Echinopsidine</li>
<li><a href="Furazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazolidone" title="Furazolidone">Furazolidone</a></li>
<li>Guineesine</li>
<li><a href="Hydralazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydralazine" title="Hydralazine">Hydralazine</a></li>
<li>Indantadol</li>
<li>Iproclozide</li>
<li><a href="Iproniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Iproniazid" title="Iproniazid">Iproniazid</a></li>
<li><a href="Isocarboxazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isocarboxazid" title="Isocarboxazid">Isocarboxazid</a></li>
<li><a href="Isoniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoniazid" title="Isoniazid">Isoniazid</a></li>
<li><a href="Linezolid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linezolid" title="Linezolid">Linezolid</a></li>
<li>Mebanazine</li>
<li>Metfendrazine</li>
<li><a href="Nialamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nialamide" title="Nialamide">Nialamide</a></li>
<li>Octamoxin</li>
<li>Paraxazone</li>
<li><a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">Phenelzine</a></li>
<li>Pheniprazine</li>
<li>Phenoxypropazine</li>
<li>Pivhydrazine</li>
<li><a href="Procarbazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procarbazine" title="Procarbazine">Procarbazine</a></li>
<li>Safrazine</li>
<li><a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> <i>MAO-A-selective:</i> Amiflamine</li>
<li>Bazinaprine</li>
<li>Befloxatone</li>
<li>Brofaromine</li>
<li>Cimoxatone</li>
<li><a href="Clorgiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Clorgiline" title="Clorgiline">Clorgiline</a></li>
<li>CX157 (Tyrima)</li>
<li>Eprobemide</li>
<li>Esuprone</li>
<li><a href="Harmala_alkaloid.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmala_alkaloid" title="Harmala alkaloid">Harmala alkaloids</a> (e.g., <a href="Harmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmine" title="Harmine">harmine</a>, <a href="Harmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmaline" title="Harmaline">harmaline</a>, harman, norharman, tetrahydroharmine)</li>
<li>Methylene blue</li>
<li>Metralindole</li>
<li><a href="Minaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Minaprine" title="Minaprine">Minaprine</a></li>
<li><a href="Moclobemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Moclobemide" title="Moclobemide">Moclobemide</a></li>
<li>Pirlindole</li>
<li>Sercloremine</li>
<li>Tetrindole</li>
<li>Toloxatone</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> <i>MAO-B selective:</i> <span class="new">Adarigiline</span></li>
<li>Almoxatone</li>
<li><small>D</small>-Deprenyl</li>
<li><a href="Ethanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethanol" title="Ethanol">Ethanol</a></li>
<li>Ladostigil</li>
<li>Lazabemide</li>
<li>Milacemide</li>
<li>Mofegiline</li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li><a href="Pargyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Pargyline" title="Pargyline">Pargyline</a><sup>‡</sup></li>
<li><a href="Rasagiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Rasagiline" title="Rasagiline">Rasagiline</a></li>
<li>Safinamide</li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline (<small>L</small>-Deprenyl)</a></li>
<li><span class="new">Sembragiline</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Phenethylamines<br><small>(<a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a>, <a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">epinephrine</a>,<br>norepinephrine)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>PAH</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine">Phenylalanine</a>→<a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">Tyrosine</a></li></ul>

<ul><li><b>Inhibitors:</b> 3,4-Dihydroxystyrene</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>TH</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">Tyrosine</a>→<a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a></li></ul>

<ul><li><b>Inhibitors:</b> 2-Hydroxyestradiol</li>
<li>2-Hydroxyestrone</li>
<li>3-Iodotyrosine</li>
<li>Aquayamycin</li>
<li>Bulbocapnine</li>
<li><a href="Metirosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Metirosine" title="Metirosine">Metirosine</a></li>
<li>Oudenone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>DBH</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a>→Norepinephrine (Noradrenaline)</li></ul>

<ul><li><b>Inhibitors:</b> Bupicomide</li>
<li><a href="Disulfiram.htm" tppabs="https://ptable.com/wiki/compounds/A/Disulfiram" title="Disulfiram">Disulfiram</a></li>
<li>Dopastin</li>
<li><a href="Fusaric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Fusaric_acid" title="Fusaric acid">Fusaric acid</a></li>
<li>Nepicastat</li>
<li>Phenopicolinic acid</li>
<li><a href="Tropolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropolone" title="Tropolone">Tropolone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>PNMT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> Norepinephrine (noradrenaline)→<a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine (adrenaline)</a></li></ul>

<ul><li><b>Inhibitors:</b> <span class="new">CGS-19281A</span></li>
<li><span class="new">SKF-64139</span></li>
<li><span class="new">SKF-7698</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>COMT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a>→<a href="3-Methoxytyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a></li>
<li><a href="3,4-Dihydroxyphenylacetic_acid-1.htm" tppabs="https://ptable.com/wiki/compounds/A/DOPAC" title="DOPAC" class="mw-redirect">DOPAC</a>→<a href="Homovanillic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Homovanillic_acid" title="Homovanillic acid">Homovanillic acid</a></li>
<li>Norepinephrine→Normetanephrine</li>
<li><a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine</a>→Metanephrine</li>
<li><a href="Dihydroxyphenylethylene_glycol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroxyphenylethylene_glycol" title="Dihydroxyphenylethylene glycol">DOPEG</a>→MOPEG</li>
<li>DOMA→<a href="Vanillylmandelic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanillylmandelic_acid" title="Vanillylmandelic acid">VMA</a></li>
<li>2-Hydroxyestradiol→<a href="2-Methoxyestradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Methoxyestradiol" title="2-Methoxyestradiol">2-Methoxyestradiol</a></li>
<li>2-Hydroxyestrone→2-Methoxyestrone</li>
<li>4-Hydroxyestradiol→4-Methoxyestradiol</li>
<li>4-Hydroxyestrone→4-Methoxyestrone</li></ul>

<ul><li><b>Inhibitors:</b> 2-Hydroxyestradiol</li>
<li>2-Hydroxyestrone</li>
<li><a href="Entacapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Entacapone" title="Entacapone">Entacapone</a></li>
<li><span class="new">Neluxicapone</span></li>
<li><a href="Nitecapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitecapone" title="Nitecapone">Nitecapone</a></li>
<li>Opicapone</li>
<li><a href="Quinalizarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinalizarin" title="Quinalizarin">Quinalizarin</a></li>
<li><a href="Tolcapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolcapone" title="Tolcapone">Tolcapone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Tryptamines<br><small>(<a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">serotonin</a>, <a href="Melatonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Melatonin" title="Melatonin">melatonin</a>)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>TPH</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Tryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptophan" title="Tryptophan">Tryptophan</a>→<a href="5-Hydroxytryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/5-HTP" title="5-HTP" class="mw-redirect">5-HTP</a></li></ul>

<ul><li><b>Inhibitors:</b> AGN-2979</li>
<li><a href="Fenclonine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenclonine" title="Fenclonine">Fenclonine (PCPA)</a></li>
<li>Telotristat ethyl</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>AANAT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a>→<a href="N-Acetylserotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylserotonin" title="N-Acetylserotonin">N-Acetylserotonin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>ASMT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="N-Acetylserotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylserotonin" title="N-Acetylserotonin">N-Acetylserotonin</a>→<a href="Melatonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Melatonin" title="Melatonin">Melatonin</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>HDC</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <small>L</small>-Histidine→<a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li></ul>

<ul><li><b>Inhibitors:</b> <a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/(%2B)-Catechin" title="(+)-Catechin" class="mw-redirect">Catechin</a></li>
<li>Alpha-Fluoromethylhistidine</li>
<li>Histidine methyl ester</li>
<li>Meciadanol</li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Tritoqualine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>HNMT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a>→<span class="new">N-Methylhistamine</span></li></ul>

<ul><li><b>Inhibitors:</b> <a href="Amodiaquine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amodiaquine" title="Amodiaquine">Amodiaquine</a></li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li><a href="Harmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmaline" title="Harmaline">Harmaline</a></li>
<li><span class="new">Metoprine</span></li>
<li><a href="Quinacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinacrine" title="Quinacrine" class="mw-redirect">Quinacrine</a></li>
<li>SKF-91488</li>
<li><a href="Tacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrine" title="Tacrine">Tacrine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>DAO</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a>→<span class="new">Imidazole acetic acid</span></li></ul>

<ul><li><b>Inhibitors:</b> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Pimagedine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Pimagedine'" tppabs="https://ptable.com/wiki/compounds/A/Pimagedine" title="Pimagedine">Pimagedine (aminoguanidine)</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><small><i><b>See also:</b> Receptor/signaling modulators • Adrenergics • Dopaminergics • Melatonergics • Serotonergics • Monoamine reuptake inhibitors • Monoamine releasing agents • Monoamine neurotoxins</i></small></div></td></tr></tbody></table></div>






<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-04" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Moclobemide&oldid=965912874  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Moclobemide&oldid=965912874'" tppabs="https://en.wikipedia.org/wiki/?title=Moclobemide&oldid=965912874">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>